US20050143662A1 - Optical imaging of subsurface anatomical structures and biomolecules - Google Patents
Optical imaging of subsurface anatomical structures and biomolecules Download PDFInfo
- Publication number
- US20050143662A1 US20050143662A1 US11/036,548 US3654805A US2005143662A1 US 20050143662 A1 US20050143662 A1 US 20050143662A1 US 3654805 A US3654805 A US 3654805A US 2005143662 A1 US2005143662 A1 US 2005143662A1
- Authority
- US
- United States
- Prior art keywords
- light
- imaging
- red
- infrared
- interest
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000012634 optical imaging Methods 0.000 title abstract description 9
- 210000003484 anatomy Anatomy 0.000 title abstract description 8
- 238000000034 method Methods 0.000 claims abstract description 76
- 238000003384 imaging method Methods 0.000 claims description 92
- 210000004369 blood Anatomy 0.000 claims description 39
- 239000008280 blood Substances 0.000 claims description 39
- 238000005286 illumination Methods 0.000 claims description 32
- 210000004204 blood vessel Anatomy 0.000 claims description 24
- 230000003287 optical effect Effects 0.000 claims description 20
- 230000010287 polarization Effects 0.000 claims description 15
- 238000001069 Raman spectroscopy Methods 0.000 claims description 14
- 230000000541 pulsatile effect Effects 0.000 claims description 12
- 230000033001 locomotion Effects 0.000 claims description 10
- 238000012014 optical coherence tomography Methods 0.000 claims description 9
- 238000001228 spectrum Methods 0.000 claims description 9
- 108010054147 Hemoglobins Proteins 0.000 claims description 8
- 102000001554 Hemoglobins Human genes 0.000 claims description 8
- 238000001161 time-correlated single photon counting Methods 0.000 claims description 7
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 6
- 238000002983 circular dichroism Methods 0.000 claims description 6
- 230000001427 coherent effect Effects 0.000 claims description 6
- MOFVSTNWEDAEEK-UHFFFAOYSA-M indocyanine green Chemical compound [Na+].[O-]S(=O)(=O)CCCCN1C2=CC=C3C=CC=CC3=C2C(C)(C)C1=CC=CC=CC=CC1=[N+](CCCCS([O-])(=O)=O)C2=CC=C(C=CC=C3)C3=C2C1(C)C MOFVSTNWEDAEEK-UHFFFAOYSA-M 0.000 claims description 6
- 229960004657 indocyanine green Drugs 0.000 claims description 6
- 230000003993 interaction Effects 0.000 claims description 6
- 229910052760 oxygen Inorganic materials 0.000 claims description 6
- 239000001301 oxygen Substances 0.000 claims description 6
- 238000010226 confocal imaging Methods 0.000 claims description 5
- 102000036675 Myoglobin Human genes 0.000 claims description 4
- 108010062374 Myoglobin Proteins 0.000 claims description 4
- 238000002106 pulse oximetry Methods 0.000 claims description 4
- INGWEZCOABYORO-UHFFFAOYSA-N 2-(furan-2-yl)-7-methyl-1h-1,8-naphthyridin-4-one Chemical compound N=1C2=NC(C)=CC=C2C(O)=CC=1C1=CC=CO1 INGWEZCOABYORO-UHFFFAOYSA-N 0.000 claims description 3
- ZGXJTSGNIOSYLO-UHFFFAOYSA-N 88755TAZ87 Chemical compound NCC(=O)CCC(O)=O ZGXJTSGNIOSYLO-UHFFFAOYSA-N 0.000 claims description 3
- 230000017531 blood circulation Effects 0.000 claims description 3
- 108010002255 deoxyhemoglobin Proteins 0.000 claims description 3
- 238000012544 monitoring process Methods 0.000 claims description 3
- 230000008569 process Effects 0.000 claims description 3
- 108010064719 Oxyhemoglobins Proteins 0.000 claims description 2
- 239000006185 dispersion Substances 0.000 claims 1
- 238000011282 treatment Methods 0.000 abstract description 7
- 238000003745 diagnosis Methods 0.000 abstract description 2
- 210000001519 tissue Anatomy 0.000 description 39
- 238000010521 absorption reaction Methods 0.000 description 22
- 239000000523 sample Substances 0.000 description 16
- 238000001444 catalytic combustion detection Methods 0.000 description 15
- 230000009286 beneficial effect Effects 0.000 description 12
- 210000003462 vein Anatomy 0.000 description 11
- 239000000835 fiber Substances 0.000 description 10
- 238000005259 measurement Methods 0.000 description 10
- 230000008901 benefit Effects 0.000 description 9
- 238000012545 processing Methods 0.000 description 9
- 230000000694 effects Effects 0.000 description 8
- 230000008859 change Effects 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- 239000013307 optical fiber Substances 0.000 description 6
- 206010046996 Varicose vein Diseases 0.000 description 5
- 239000012491 analyte Substances 0.000 description 5
- 230000001419 dependent effect Effects 0.000 description 5
- 230000005284 excitation Effects 0.000 description 5
- 238000003331 infrared imaging Methods 0.000 description 5
- 238000000853 optical rotatory dispersion Methods 0.000 description 5
- 230000005855 radiation Effects 0.000 description 5
- 208000027185 varicose disease Diseases 0.000 description 5
- 210000001367 artery Anatomy 0.000 description 4
- 230000005540 biological transmission Effects 0.000 description 4
- 230000002708 enhancing effect Effects 0.000 description 4
- 210000003743 erythrocyte Anatomy 0.000 description 4
- 230000000149 penetrating effect Effects 0.000 description 4
- 230000002792 vascular Effects 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 3
- 230000000740 bleeding effect Effects 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000002674 endoscopic surgery Methods 0.000 description 3
- 238000002267 linear dichroism spectroscopy Methods 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 230000003595 spectral effect Effects 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- 230000000007 visual effect Effects 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 239000006096 absorbing agent Substances 0.000 description 2
- 230000015271 coagulation Effects 0.000 description 2
- 238000005345 coagulation Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000002059 diagnostic imaging Methods 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 238000000799 fluorescence microscopy Methods 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 238000005305 interferometry Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 238000011176 pooling Methods 0.000 description 2
- 150000004032 porphyrins Chemical class 0.000 description 2
- 239000010453 quartz Substances 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 230000003068 static effect Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 229940124597 therapeutic agent Drugs 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000012876 topography Methods 0.000 description 2
- 238000002834 transmittance Methods 0.000 description 2
- 238000001851 vibrational circular dichroism spectroscopy Methods 0.000 description 2
- 238000012935 Averaging Methods 0.000 description 1
- 208000019838 Blood disease Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 206010043189 Telangiectasia Diseases 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 238000000149 argon plasma sintering Methods 0.000 description 1
- 230000002238 attenuated effect Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000004624 confocal microscopy Methods 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- BFMYDTVEBKDAKJ-UHFFFAOYSA-L disodium;(2',7'-dibromo-3',6'-dioxido-3-oxospiro[2-benzofuran-1,9'-xanthene]-4'-yl)mercury;hydrate Chemical compound O.[Na+].[Na+].O1C(=O)C2=CC=CC=C2C21C1=CC(Br)=C([O-])C([Hg])=C1OC1=C2C=C(Br)C([O-])=C1 BFMYDTVEBKDAKJ-UHFFFAOYSA-L 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000005670 electromagnetic radiation Effects 0.000 description 1
- 238000000572 ellipsometry Methods 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 238000001506 fluorescence spectroscopy Methods 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229910002804 graphite Inorganic materials 0.000 description 1
- 239000010439 graphite Substances 0.000 description 1
- 231100001261 hazardous Toxicity 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 238000002129 infrared reflectance spectroscopy Methods 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 230000036210 malignancy Effects 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 238000006213 oxygenation reaction Methods 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 238000000515 polarization modulation infrared reflection--adsorption spectroscopy Methods 0.000 description 1
- 238000012805 post-processing Methods 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000004233 retinal vasculature Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 238000007632 sclerotherapy Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000010183 spectrum analysis Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 208000009056 telangiectasis Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000000211 third ventricle Anatomy 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 210000005166 vasculature Anatomy 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0062—Arrangements for scanning
- A61B5/0066—Optical coherence imaging
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0071—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence by measuring fluorescence emission
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0075—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence by spectroscopy, i.e. measuring spectra, e.g. Raman spectroscopy, infrared absorption spectroscopy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4887—Locating particular structures in or on the body
- A61B5/489—Blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
- A61B1/04—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor combined with photographic or television appliances
- A61B1/043—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor combined with photographic or television appliances for fluorescence imaging
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
- A61B1/04—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor combined with photographic or television appliances
- A61B1/045—Control thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/36—Image-producing devices or illumination devices not otherwise provided for
- A61B2090/364—Correlation of different images or relation of image positions in respect to the body
- A61B2090/366—Correlation of different images or relation of image positions in respect to the body using projection of images directly onto the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0062—Arrangements for scanning
- A61B5/0068—Confocal scanning
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0082—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes
- A61B5/0084—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes for introduction into the body, e.g. by catheters
- A61B5/0086—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes for introduction into the body, e.g. by catheters using infrared radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/026—Measuring blood flow
- A61B5/0261—Measuring blood flow using optical means, e.g. infrared light
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/318—Heart-related electrical modalities, e.g. electrocardiography [ECG]
- A61B5/346—Analysis of electrocardiograms
- A61B5/349—Detecting specific parameters of the electrocardiograph cycle
- A61B5/352—Detecting R peaks, e.g. for synchronising diagnostic apparatus; Estimating R-R interval
Definitions
- the present invention relates generally to the fields of optical imaging and medical diagnosis. More specifically, the present invention relates to advanced methods of optical imaging of subsurface anatomical structures and biomolecules.
- infrared radiant energy is useful in non-invasive imaging of anatomical structures since it is relatively penetrating in tissue; the wavelengths of radiant energy from about 600 nm to about 1100 nm penetrates tissue quite well, when compared to visible, ultraviolet, or mid- to far infrared radiant energy. Furthermore, biomolecules exhibit absorption features in this red to near-infrared region of the spectrum due to electronic and vibrational/rotational absorption.
- the prior art is deficient in the lack of effective means of imaging subsurface anatomical structures and biomolecules by using red and infrared radiant energy.
- the present invention fulfills this long-standing need and desire in the art.
- the present invention provides various methods/systems of optical imaging of subsurface anatomical structures and biomolecules utilizing red and infrared radiant energy. Such methods enhance contrast in medical imaging, and are generally useful in non-invasive and relatively low cost imaging instruments.
- the techniques used include pulsatile enhanced imaging, confocal enhanced imaging, Raman enhanced imaging, laser speckle enhanced imaging, multiphoton interaction enhanced imaging, optical coherence tomography enhanced imaging, time correlated single photon counting enhanced imaging, and polarization enhanced imaging.
- the present invention also provides a method of enhancing vascular contrast for imaging, comprising the step of applying the system disclosed herein in combination with the usage of exogenous chromophores or a range of other molecules which have tendency of concentrating in the tissue of interest.
- Still provided is a method of detecting a disease in a subject comprising the steps of applying the system disclosed herein to the subject to obtain an optical image, and then comparing the image with a control image obtained from a normal subject, wherein any difference between the two images is indicative of a possibility of having a disease in the test subject.
- FIG. 1A shows a dual wavelength illumination device optionally employing an electrode to synchronize the video imaging with the pulse rate.
- FIG. 1B shows a method for imaging in multiple wavelengths whereupon optical filters are sequentially inserted into the image axis at a rate which is synchronized with the video capture rate.
- FIG. 2 shows a confocal imaging device whereby white light illumination and optionally infrared illumination and/or white light illumination are used to image subsurface blood vessels.
- FIG. 3 shows an imaging system employing Raman scattered photons and a scanner positioned in front of the spectrograph optical system or the infrared laser illumination.
- FIG. 4 shows a blood vessel imaging device where motion detection is employed.
- FIG. 5 shows a blood vessel imager where multiphoton effects are used for imaging.
- FIG. 6 shows an optical coherence tomographic blood vessel imager.
- FIGS. 7A-7F show various ways in which polarized light and polarizing filters over the detector can be used to enhance blood vessel image contrast.
- FIGS. 7C-7F make use of an active device called a photoelastic modulator which can be used in the creation and analysis of polarized radiant energy.
- FIG. 8 illustrates one configuration for altering the intensity profile of the incident light to compensate for uneven topography of the imaged anatomic object.
- FIG. 9 shows one configuration for a blood vessel viewer including a plurality of arms to hold an illumination source and video detector over the region-of-interest.
- the present invention is directed to various methods/systems of optical imaging of subsurface anatomical structures and biomolecules utilizing red and infrared radiant energy. Such methods enhance contrast in medical imaging, and are generally useful in non-invasive and relatively low cost imaging instruments.
- a method/system of enhancing optical imaging of an anatomical structure or a biomolecule utilizing one or more techniques selected from the group consisting of pulsatile enhanced imaging, confocal enhanced imaging, Raman enhanced imaging, laser speckle enhanced imaging, multiphoton interaction enhanced imaging, optical coherence tomography enhanced imaging, time correlated single photon counting enhanced imaging, and polarization enhanced imaging.
- a method of enhancing vascular contrast for imaging comprising the step of applying the system disclosed herein in combination with the usage of exogenous chromophores or a range of other molecules which have tendency of concentrating in the tissue of interest.
- a method of detecting a disease in a subject comprising the steps of applying the system disclosed herein to the subject to obtain an optical image, and then comparing the image with a control image obtained from a normal subject, wherein any difference between the two images is indicative of a possibility of having a disease in the test subject.
- a method of treating a subject having a disease, or further monitoring the treatment by applying to the subject with the system disclosed herein in combination with the administration of therapeutic agents including laser energy.
- Pulse oximeters are relatively common devices used to measure the percent oxygen saturation of blood, wherein red ( ⁇ 1 ⁇ 660 nm) and near infrared ( ⁇ 2 ⁇ 940 nm) radiant energy are passed through tissue (typically the fingertip). Using this device, it is possible to obtain a measurement of oxygen saturation of the blood based on the relative signals transmitted through the fingertips at each wavelength, knowing the absorption characteristics of the pertinent absorbing chromophores (tissue, oxygenated hemoglobin or HbO 2 , deoxygenated hemoglobin or Hb), and after extensive calibration of the device with a direct measurement of blood oxygenation.
- One important operating characteristic that makes the pulse-oximeters useful is that they can discern between arterial and non-arterial absorption by discriminating between time-varying signals (due to the heart pumping and more evident in arterial blood) and non-varying signals (venous blood and tissue).
- FIG. 1 shows an imaging device (e.g. charge-coupled device or CCD video camera, or vidicon) used to visualize an anatomic structure or region of interest that employs concepts used in pulse oximetry.
- the detector captures an image, for example, every ⁇ fraction (1/30) ⁇ th of a second, and so the illuminating light is alternately pulsed once every ⁇ fraction (1/30) ⁇ th second.
- the images captured can be analyzed mathematically similar to standard transillumination pulse-oximeters except in this case reflectance, R, is measured, and not transmittance, T.
- the signal can be decomposed into an time-varying signal (AC) and steady state (DC) signal, whereby the former is due to absorption within arteries (and to a much lesser degree, veins) while the latter is primarily due to non-arterial absorption.
- an electrocardiogram (ECG) electrode could be used to monitor the heartbeat in order to match the phase of the signal with the heartbeat, thus achieving the same aforementioned result.
- ECG electrocardiogram
- this methodology would allow one to optically differentiate arterial blood absorption from absorption due to other biomolecular species, such as deoxygenated blood.
- it could optionally be used to measure blood oxygen saturation, which when combined with the imaging information, provides useful diagnostic information.
- Another way to obtain sequential images at different wavelengths is to use a rotating filter wheel in front of the camera and a single broadband illumination source that produces radiant energy at both the necessary wavelengths, ⁇ 1 and ⁇ 2 ( FIG. 1B ).
- the rotation rate and phase of the optical filter wheel could be adjusted to maximize the AC signal (and thus would be in phase with the pulsatile arterial flow), or could be controlled by a pulse rate signal from an optional ECG electrode.
- Myoglobin is a form of hemoglobin that transports oxygen in muscles and which provides much of the visual appearance of color in muscles.
- the absorption spectrum of myoglobin is different from oxy- and deoxyhemoglobin. This difference can be used to differentiate hemoglobin contained within vessels from myoglobin in vessel walls, muscle or other tissue, thus producing good blood-tissue contrast.
- extravascular blood will not optically change in a pulsatile fashion as will blood in arteries (and to a lesser extent, veins), thus the aforementioned pulsatile imaging scheme can be used to differentiate intervascular blood from extravascular blood.
- confocal imaging The concept of rejecting light scattered from locations other than the point being imaged (that is, with coordinates x,y,z), by using apertures in the imaging system, is referred to as confocal imaging.
- This concept has been used to “optically section” microscopic specimens being viewed with a microscope.
- Confocal microscopy normally uses white light illumination, or ultraviolet to green illumination to induce fluorescence in the sample. The former illumination results in significant chromatic aberrations in the final image, while the latter provides only a fluorescent image.
- Narrow band illumination through the use of diode lasers or bandpass filtered broadband light sources would be optimal ( FIG. 2 ).
- ROI region-of-interest
- HbO 2 and Hb region-of-interest
- Illumination at these wavelengths could be alternated with illumination using white light so that a normally appearing image of the region-of-interest would also result. This could allow one to visualize blood vessels, for example, below other normally appearing intervening structures that reduce or eliminate the ability to visualize the vessels.
- Raman spectroscopy is a light scattering technique that uses (typically) laser radiation to excite the sample, whereby the scattered radiation emitted by the sample is analyzed.
- Emission data has two main characteristics: the frequencies at which the sample emits the radiation (a small number of the incident photons, perhaps only 1 in 10 6 , is emitted at frequencies different from that of the incident light), and the intensities of the emissions. Determining the frequencies allows identification of the sample's molecular makeup, since chemical functional groups are known to emit specific frequencies and emission intensity is related to the amount of the analyte present.
- highly sensitive imaging light detectors e.g. CCDs
- efficient optics such as transmission holographic gratings and notch filters
- the detector (if it is not an imaging type) can be scanned. Still alternatively, a two-dimensional imaging detector, such as a CCD, can be used. In any case, the strong molecular specificity of Raman scattering would allow for good rejection of signals not pertaining to the molecule of interest.
- FIG. 4 shows an imaging system being used to detect blood within a vessel.
- the imaged vessel and surrounding structures are illuminated with radiant energy produced by a laser, preferably in the near infrared region of the spectrum so relatively deep penetration of the radiant energy occurs, and yet is reflected from red blood cells (RBC); for example, 805 nm light.
- RBC red blood cells
- the reflected radiant energy can be captured by a detector, which is positioned behind an aperture.
- Any change in the speckle pattern results in a change in the detector's signal output.
- Any changing speckle pattern is a consequence of RBC movement. If the infrared laser is scanned, then an image of the speckle pattern can be built up and spatially dependent RBC movement can be detected, thus providing a means with which to detect blood vessels. Again, a normally appearing image using white-light illumination could be captured and the blood-vessel movement information could be superimposed on the image.
- photons with a wavelength ⁇ , interact with an atom or molecule which normally would not absorb at ⁇ , but which does absorb at a different ⁇ .
- fluorescein which has an absorption peak around 500 nm can be induced to fluoresce when irradiated with two photons with a wavelength of 1000 nm, that arrive virtually simultaneously.
- Three-photon excitation can also be used in certain circumstances, but in this case the wavelength of the photons must be 1 ⁇ 3 that of the wavelength of absorption. This multi-photon effect requires lasers which produce high peak powers (e.g.
- This multi-photon effect can be used for fluorescence imaging as the requisite high photon density can be made to occur only at the focus of the laser beam, which can then be scanned in three dimensions.
- the benefits of multi-photon excitation is that the incident radiant energy is not attenuated by absorption of the fluorochrome above the plane of focus and the longer excitation wavelengths used are less Rayleigh scattered.
- Such radiant energy is quite penetrating in tissue, and yet will interact with blood if the photon density per unit time is large enough. It is therefore possible to obtain imaging information ( FIG. 5 ) using a pulsed laser producing near infrared radiant energy.
- a pulsed laser producing near infrared radiant energy.
- such an imaging scheme may benefit from using a Q-switched Nd:YAG laser (1064 nm), as such lasers are relatively inexpensive and fortuitously blood absorbs strongly at 532 nm.
- the 532 nm scattered information could be collected in synchrony with the pulsed Nd:YAG laser.
- white light or infrared images could be captured. Comparison of the two could be used to determine the location of the blood (or other light absorbing/scattering chromophore) in the field of view.
- OCT optical coherence tomography
- Low-coherence interferometry e.g. white-light Michelson interferometry
- High resolution depth-dependent imaging is obtained by focusing light from an optical low coherence source (e.g. LED) on the biological tissue and interfering the backscattered intensities with the incident light ( FIG. 6 ).
- Images in the first two dimensions are obtained by performing the interferometric measurement as a function of transverse (x,y) positions in the tissue.
- Third dimension (depth) information in the tissue is collected by varying the reference arm pathlength axially (z position) in the interferometer.
- Optical coherence tomography is beneficial in that is does not require an illumination source with a long coherence length (e.g. a laser) and can be done with the use of optical fibers.
- Time-correlated single-photon counting is a statistical technique which may be used to measure the time profile of the emission of a sample following excitation by a short light pulse.
- the time delay between a trigger (“start”) pulse, which is fixed in time with respect to the excitation pulse, and the moment of arrival of a photon emitted by the sample and then detected by a photomultiplier (“stop” pulse) is recorded.
- start a trigger
- stop a photomultiplier
- Time-correlated single-photon counting is a commonly used technique in fluorescence spectroscopy due to its wide dynamic range, high time resolution and high sensitivity. Time resolutions of the order of 50 ps (FWHM) are easily achievable with commercial ultrafast laser and detector systems.
- a mode-locked argon-ion laser is used to synchronously pump a cavity-pumped dye laser.
- the resultant train of picosecond pulses may be coupled into an optical fiber in contact with the sample under investigation.
- the pulse shape changes as it propagates through the medium. This is due to the fact that photon pathlengths are altered through interactions (scattering and absorbing) with the medium. In fact, the optical properties of the medium may be inferred from the shape of the emitted pulses.
- the emitted pulses are collected with an optical fiber positioned on the sample at a known distance from the input fiber.
- the distal end of the collection fiber is in contact with the detector, which, for ultrafast applications, is a microchannel plate-photomultiplier tube (MCP-PMT).
- MCP-PMT microchannel plate-photomultiplier tube
- the optical properties (scattering and absorption) of the material may be obtained through non-linear least squares fitting of the data (amplitude vs. time spectra) to a model function.
- a diffusion model is commonly used to fit the data.
- Analytic solutions of the diffusion equation in homogeneous media exist for various simple geometries. This data (absorption and scattering coefficients) can be collected during scanning in the x-y plane in order to build up an image.
- Depth z dependent information could be obtained using one of the depth discriminate techniques, such as OCT or confocal, described above.
- Circular dichroism (CD) and optical rotatory dispersion (ORD) are polarization dependent measurements whereby circular dichroism measures a difference between the absorption in matter of radiant energy that is left and right circularly polarized light, while optical rotatory dispersion measures the difference in the refractive indices for left (L) and right (R) circularly polarized light. If a biomolecule is optically active, i.e., if dissymmetric and non-superimposable mirror images of the molecule occur, circularly polarized light interacts with the molecule depending on the handedness of the light. Molecular shape and orientation also determines the degree to which linearly polarized light interacts with a molecule.
- polarizing sunglasses have absorbing chromophores that are mostly oriented horizontally; thus when light specularly reflected from a roadway (which is, to a degree, linearly polarized with the axis of polarization oriented horizontally), then it is absorbed by the chromophores.
- Unpolarized light retroreflected from a tissue interface will have a degree of linear polarization; incident linearly polarized light retroreflected ( FIG. 7A ) from deeper within the tissue will loose the initial polarization, depending on how many scattering events occur within the tissue; the more scattering events that photon experiences, the more the polarization becomes random with respect to the polarization of the injected photon.
- PEM photoelastic modulator
- optically active molecules such as glucose can be detected by transmission measurements using CD or optical rotatory dispersion.
- PM-IRRAS stands for Polarization Modulation Infrared Reflection-Absorption Spectroscopy. It is the differential IR absorption between the s- and p-linearly polarized light for the molecules in a tissue ( FIG. 7C ).
- Vibrational circular dichroism (VCD) is the differential absorption between left and right circularly polarized light. It is a measurement of the optical activity for chiral molecules ( FIG. 7E ).
- Linear dichroism is the differential absorption between two orthogonal, linearly polarized states.
- Linear dichroism is a measurement of the sample's bulk property that is a result of the regular orientation of the molecules in the sample ( FIG. 7F with the PEM set at 0° and phase-sensitive detector at the 2 nd harmonic).
- Image processing devices which can manipulate digital image data quickly, would be beneficially used in any of the above methods.
- Hamanatsu Photonic Systems (Bridgewater, N.J.) sells a unit which can perform real-time edge enhancement, uneven illumination compensation and frame averaging.
- edge enhancement can be done by high-pass filtering the transform prior to performing the inverse Fast Fourier Transform.
- One very important post-processing algorithm involves pixel-stretching, whereupon the contrast of a low contrast image is increased by altering the video image pixel values to utilize the full spread of values (e.g. 256) available in the digitizer.
- ROI region-of-interest
- ICG Indocyanine Green
- ICG Indocyanine Green
- a well know agent which has been used for many years in quantifying cardiac output and imaging retinal vasculature. When dissolved in plasma, it has an absorption maximum at about 800 nm.
- multiple-wavelength illumination and/or detection whereby one of the images captured was illuminated or detected around 800 nm, and the other at a wavelength where indocyanine green is only weaking absorbing (say, for example, 660 nm), then it is possible to differentially image vasculature.
- ⁇ -aminolevulinic acid ⁇ -ALA
- porphyrins are strongly absorbing and fluorescent, and so this compound combined with the above discussed imaging techniques can be used to identify (and actually treat) cancer.
- Carbon and graphite are strong absorbers of near infrared radiant energy. By coating gloves, instruments, etc, in a thin layer of these materials would appear dark in an infrared imaging system.
- Another way to enhance the visual appearance of blood vessels in these images is to use a process sometimes referred to, by astronomers, as “blink” imaging.
- the eye (and brain) are apparently quite sensitive to small changes in the appearance of a visual field, more so than small differences in a static field. It would therefore be beneficial to configure the image processing and display system such that the image would switch rapidly (e.g. 2 Hz) between a white-light illuminated black-and-white or color image and the infrared image. This mode of display would serve to enhance the visualization of the blood vessels.
- Optical fibers can be used to guide the radiant energy of a laser down an endoscope, whereupon it is used to cut, coagulate, or induce fluorescence in tissue. It would be beneficial in certain surgeries, such as third ventriculostomy, to be able to use infrared imaging to identify sensitive subsurface structures such as blood vessels, and then to use the radiant energy produced by a laser (the 2.94 micron wavelength radiation produced by an Er:YAG laser, for example) to produce a fenestration in the membrane (floor of the third ventricle). The use of the imaging technology in conjunction with therapeutic laser radiant energy would be important clinically.
- Some of the embodiments of the inventions described will be too bulky to mount on devices that can be easily manipulate by the health-care provider. It might therefore, in certain cases, be beneficial to optically guide the image from a small handpiece over to the image collection and processing device, which could be positioned on a table nearby.
- Coherent imaging fiber bundles are suitable for this purpose. The input end of the bundle is positioned in the image plane of an optical system directed at the ROI, and the output end of the bundle is positioned in the object plane of the image collection system. This arrangement is light and flexible, thus, gives the health-care provider necessary freedom-of-movement.
- magnification is a useful addition to the imaging device in many instances. For example, blood vessels in babies are very small and quite difficult to see. Small, telangiectasia vessels are also difficult to see during treatment.
- the combination of the image contrast improving methods described herein and optical magnification would serve to improve clinical efficiency during blood vessel puncture procedures or treatment of diseased blood vessels.
- the illumination systems used in the described applications can also be applied as transilluminators.
- tissues such as skin or mucous membranes, whether applied externally or internally, much of the light scatters through the tissues and illuminates the area beneath the skin and laterally. This scattered light illuminates tissue structures in proximity to the site where the photons are injected.
- an infrared sensitive detector and infrared incident light or light which has an infrared component it is possible to observe subsurface anatomic structures such as blood vessels beneath the skin.
- any imaging system that is most beneficial is the one that does not need to be hand-held or manipulated. Furthermore, it is of benefit that the imaging system is possible to simultaneously view the actual region of interest on the patient, if it is required that the image of the ROI needs to be displayed for the provider.
- the video information could be inputted into a video projector whereupon the image of the ROI is projected back onto the actual ROI on the patient.
- the projected image could be enhanced so that the structures of interest (typically blood vessels) are made as contrasty as possible and the rest of the image is made uniform.
- the projection would serve to outline the actual position of the structures on the patient, thus enhancing the ease with which they are manipulated b y the health-care provider.
- Another way to achieve a similar effect is to project the video image onto a partial reflecting screen which reflects the image back to the provider; the subject is positioned on the opposite side of the screen so that the video image appears to the provider to be superimposed on the actual subject.
- This form of display is similar to that used in fighter-aircraft and is sometimes called a heads-up-display.
- Another way to achieve the same effect is to control the gain in each pixel of the CCD individually, instead of the typical way whereby they are adjusted together.
- the health-care provider could outline an ROI on a video screen with a mouse, and the computer to which the screen is interfaced could then direct information to the CCD video camera such that the gain of the relevant pixels are adjusted, and the rest of the pixels in the image are ignored.
- a similar sort of non-uniform gain is used in, for example, the Hamamatsu C2400-1 controller which allows the user to adjust the gain of the CCD in four quadrants of the image by adjusting four potentiometers.
- the infrared imaging technology described herein would be useful during the therapeutic processes (e.g. vein stripping, laser irradiation, sclerotherapy, etc.) by allowing the surgeon to visualize the vessels accurately ( FIG. 9 ).
- This device could have a plurality of support arms which serve to allow placement of the device on the patient thus freeing the hands of the surgeon.
- the device could be positioned on a support employing a ball joint such that it could be positioned in any way by the surgeon and will be kept in that position.
- the support arms could have incorporated an optical wave guide, such as an optical fiber bundles, which transmits illumination from the source to the surface of the skin.
- the arms terminate in an infrared filter and optionally a polarizing filter.
- the light will be directed out of the terminal portion of the arms either perpendicularly to the skin surface, or at an oblique angle directed into the ROI.
- a video camera can be affixed to the light source such that it images the ROI; the output of the camera is conducted through a cable to the video controller and/or monitor.
- varicose veins may be treated by intraluminal insertion of an optical fiber which guides laser radiant energy (e.g. Nd:YAG 1064 nm radiation) into the vessel and inducing coagulation.
- laser radiant energy e.g. Nd:YAG 1064 nm radiation
- This procedure would further be improved as the fiber could be coated in an infrared absorbing agent (such as ICG) whereby it could be imaged with the technology discussed herein.
- Endoscopic surgery such as a third ventriculostomy, would benefit from the technology described herein. It is always important for the endoscopic surgeon to avoid dissecting blood vessels during insertion and advancement of the endoscope.
- the infrared imaging technology and other blood discrimination techniques described herein would be of benefit in allowing the endoscopist to avoid such vessels.
- Measuring analyte levels in blood or other tissues with minimally invasive techniques is a very desirable objective.
- a problem encountered during optical spectral measurements of blood analyte levels is the inability to measure the volume of tissue interrogated. This problem is further compounded by the fact that differences may exist between analyte concentrations extravascularly versus intravascularly. These differences may be difficult to differentiate, resulting in skewed values.
- the vessel imaging technology described herein allows for the blood in a vessel to be identified. In other words, the blood can be located. Thus, in effect, a virtual optical isolation of a volume of blood may be performed. Once the volume is isolated in this way, the available spectral analysis techniques could be further employed to obtain the information of interest regarding analyte concentration, or regarding any blood disorders that are characterized by unique spectral shifts.
- a disposable shield in many of the aforementioned methods such that any biological material (blood, saliva, ablated tissue, etc.) could not contaminate the imaging process.
- a disposable plastic sheath that covers the objective lens, scanner and/or camera of the imaging system would be useful.
- the contact probe illustrated in FIG. 9 could itself be disposable.
- disposable plastic sheaths could be also employed on each of the components that actually touches the patient.
- An infrared sensitive CCDvideo camera e.g. Hamamatsu C2400-79, Hamamatsu Photonic Systems, Bridgewater, N.J.
- an image processing and analysis system Hamamatsu Argus-20
- a 250 W quartz incandescent light source is optically coupled into a light transmitting fiber bundle which is coupled to an endoscope (e.g. Smith & Nephew Dyonics No. 3626S focusing video arthroscope).
- the proximal end of the endoscope is connected to a custom-made coherent fiber optic bundle (Schott Fiber Optics, MA) which carries the imaging information to the infrared camera.
- an infrared long-pass filter e.g.
- a macrolens on a c-mount, attached to the CCD camera, is used to image the end of the fiber bundle.
- the image processing unit is set to enhance edges and frame average in order to minimize the appearance of noise in the image.
- An infrared sensitive CCD video camera (e.g. Dage-MTI CCD 300) was fixed with a 19-38 mm zoom lens and the output was sent to a standard video monitor.
- An optical infrared long-pass filter (Edmund Scientific, Inc.) was positioned in front of the lens of the video camera. The device was used to image the varicose veins of a patient undergoing surgical removal of the veins.
- the (epi-) illumination was optionally a 30 W quartz camcorder light source, which had a Kodak Wratten No.
Abstract
The present invention provides various methods/systems of optical imaging of subsurface anatomical structures and biomolecules utilizing red and infrared radiant energy. Also provided are various applications of such methods/systems in medical diagnosis and treatment.
Description
- This non-provisional patent application claims benefit of provisional patent application U.S. Ser. No. 60/201,592, filed May 3, 2000, now abandoned.
- 1. Field of the Invention
- The present invention relates generally to the fields of optical imaging and medical diagnosis. More specifically, the present invention relates to advanced methods of optical imaging of subsurface anatomical structures and biomolecules.
- 2. Description of the Related Art
- The importance of imaging structures and biomolecules in humans is self-evident. Recently, many groups of investigators have been trying to develop optical imaging techniques in order to supercede, or reduce the requirements of using expensive and potentially harmful techniques including x-rays, ultrasound or magnetic and radio-frequency fields. Optical imaging techniques employing non-ionizing electromagnetic radiation are not harmful to biological tissue, and so are less hazardous and thus less expensive. However, there is a major limitation in using ultraviolet, visible and infrared radiant electromagnetic energy for imaging in that most tissues are highly scattering, and often strongly absorbing to such photons.
- Nevertheless, infrared radiant energy is useful in non-invasive imaging of anatomical structures since it is relatively penetrating in tissue; the wavelengths of radiant energy from about 600 nm to about 1100 nm penetrates tissue quite well, when compared to visible, ultraviolet, or mid- to far infrared radiant energy. Furthermore, biomolecules exhibit absorption features in this red to near-infrared region of the spectrum due to electronic and vibrational/rotational absorption.
- The prior art is deficient in the lack of effective means of imaging subsurface anatomical structures and biomolecules by using red and infrared radiant energy. The present invention fulfills this long-standing need and desire in the art.
- The present invention provides various methods/systems of optical imaging of subsurface anatomical structures and biomolecules utilizing red and infrared radiant energy. Such methods enhance contrast in medical imaging, and are generally useful in non-invasive and relatively low cost imaging instruments. The techniques used include pulsatile enhanced imaging, confocal enhanced imaging, Raman enhanced imaging, laser speckle enhanced imaging, multiphoton interaction enhanced imaging, optical coherence tomography enhanced imaging, time correlated single photon counting enhanced imaging, and polarization enhanced imaging.
- The present invention also provides a method of enhancing vascular contrast for imaging, comprising the step of applying the system disclosed herein in combination with the usage of exogenous chromophores or a range of other molecules which have tendency of concentrating in the tissue of interest.
- Still provided is a method of detecting a disease in a subject, comprising the steps of applying the system disclosed herein to the subject to obtain an optical image, and then comparing the image with a control image obtained from a normal subject, wherein any difference between the two images is indicative of a possibility of having a disease in the test subject.
- Further provided is a method of treating a subject having a disease, or further monitoring the treatment, by applying to the subject with the system disclosed herein in combination with the administration of therapeutic agents including laser energy.
- Other and further aspects, features, and advantages of the present invention will be apparent from the following description of the presently preferred embodiments of the invention given for the purpose of disclosure.
- So that the matter in which the above-recited features, advantages and objects of the invention, as well as others which will become clear, are attained and can be understood in detail, more particular descriptions of the invention briefly summarized above may be had by reference to certain embodiments thereof which are illustrated in the appended drawings. These drawings form a part of the specification. It is to be noted, however, that the appended drawings illustrate preferred embodiments of the invention and therefore are not to be considered limiting in their scope.
-
FIG. 1A shows a dual wavelength illumination device optionally employing an electrode to synchronize the video imaging with the pulse rate.FIG. 1B shows a method for imaging in multiple wavelengths whereupon optical filters are sequentially inserted into the image axis at a rate which is synchronized with the video capture rate. -
FIG. 2 shows a confocal imaging device whereby white light illumination and optionally infrared illumination and/or white light illumination are used to image subsurface blood vessels. -
FIG. 3 shows an imaging system employing Raman scattered photons and a scanner positioned in front of the spectrograph optical system or the infrared laser illumination. -
FIG. 4 shows a blood vessel imaging device where motion detection is employed. -
FIG. 5 shows a blood vessel imager where multiphoton effects are used for imaging. -
FIG. 6 shows an optical coherence tomographic blood vessel imager. -
FIGS. 7A-7F show various ways in which polarized light and polarizing filters over the detector can be used to enhance blood vessel image contrast.FIGS. 7C-7F make use of an active device called a photoelastic modulator which can be used in the creation and analysis of polarized radiant energy. -
FIG. 8 illustrates one configuration for altering the intensity profile of the incident light to compensate for uneven topography of the imaged anatomic object. -
FIG. 9 shows one configuration for a blood vessel viewer including a plurality of arms to hold an illumination source and video detector over the region-of-interest. - The present invention is directed to various methods/systems of optical imaging of subsurface anatomical structures and biomolecules utilizing red and infrared radiant energy. Such methods enhance contrast in medical imaging, and are generally useful in non-invasive and relatively low cost imaging instruments.
- In one embodiment of the present invention, there is provided a method/system of enhancing optical imaging of an anatomical structure or a biomolecule utilizing one or more techniques selected from the group consisting of pulsatile enhanced imaging, confocal enhanced imaging, Raman enhanced imaging, laser speckle enhanced imaging, multiphoton interaction enhanced imaging, optical coherence tomography enhanced imaging, time correlated single photon counting enhanced imaging, and polarization enhanced imaging.
- In another embodiment of the present invention, there is provided a method of enhancing vascular contrast for imaging, comprising the step of applying the system disclosed herein in combination with the usage of exogenous chromophores or a range of other molecules which have tendency of concentrating in the tissue of interest.
- In still another embodiment of the present invention, there is provided a method of detecting a disease in a subject, comprising the steps of applying the system disclosed herein to the subject to obtain an optical image, and then comparing the image with a control image obtained from a normal subject, wherein any difference between the two images is indicative of a possibility of having a disease in the test subject.
- In yet another embodiment of the present invention, there is provided a method of treating a subject having a disease, or further monitoring the treatment, by applying to the subject with the system disclosed herein in combination with the administration of therapeutic agents including laser energy.
- The following examples are given for the purpose of illustrating various embodiments of the invention and are not meant to limit the present invention in any fashion.
- Pulsatile Enhanced Imaging
- Pulse oximeters are relatively common devices used to measure the percent oxygen saturation of blood, wherein red (λ1≈660 nm) and near infrared (λ2≈940 nm) radiant energy are passed through tissue (typically the fingertip). Using this device, it is possible to obtain a measurement of oxygen saturation of the blood based on the relative signals transmitted through the fingertips at each wavelength, knowing the absorption characteristics of the pertinent absorbing chromophores (tissue, oxygenated hemoglobin or HbO2, deoxygenated hemoglobin or Hb), and after extensive calibration of the device with a direct measurement of blood oxygenation. One important operating characteristic that makes the pulse-oximeters useful is that they can discern between arterial and non-arterial absorption by discriminating between time-varying signals (due to the heart pumping and more evident in arterial blood) and non-varying signals (venous blood and tissue).
-
FIG. 1 shows an imaging device (e.g. charge-coupled device or CCD video camera, or vidicon) used to visualize an anatomic structure or region of interest that employs concepts used in pulse oximetry. The illuminating light consists of alternating pulses of radiant energy produced by, for example, light-emitting diodes (LEDs) filtered with a bandpass filter, or diode lasers, to produce radiant energy impinging on the surface with a wavelength of, for example, λ1=660 and λ1=940 nm. The detector captures an image, for example, every {fraction (1/30)}th of a second, and so the illuminating light is alternately pulsed once every {fraction (1/30)}th second. The images captured can be analyzed mathematically similar to standard transillumination pulse-oximeters except in this case reflectance, R, is measured, and not transmittance, T. The mathematical analysis is similar when one considers that optical density, OD, is related to R by OD=−Log(R) and T=1−R. In a fashion similar to pulse oximetry, the signal can be decomposed into an time-varying signal (AC) and steady state (DC) signal, whereby the former is due to absorption within arteries (and to a much lesser degree, veins) while the latter is primarily due to non-arterial absorption. - Alternatively, an electrocardiogram (ECG) electrode could be used to monitor the heartbeat in order to match the phase of the signal with the heartbeat, thus achieving the same aforementioned result. In any case, this methodology would allow one to optically differentiate arterial blood absorption from absorption due to other biomolecular species, such as deoxygenated blood. Furthermore, it could optionally be used to measure blood oxygen saturation, which when combined with the imaging information, provides useful diagnostic information.
- Another way to obtain sequential images at different wavelengths is to use a rotating filter wheel in front of the camera and a single broadband illumination source that produces radiant energy at both the necessary wavelengths, λ1 and λ2 (
FIG. 1B ). The rotation rate and phase of the optical filter wheel could be adjusted to maximize the AC signal (and thus would be in phase with the pulsatile arterial flow), or could be controlled by a pulse rate signal from an optional ECG electrode. - The aforementioned discussion of using multiple wavelengths of radiant energy to achieve imaging contrast can be used in a similar fashion to provide contrast between vessels and tissue and/or hemoglobin within blood vessels versus extravascular hemoglobin. Myoglobin (Mb) is a form of hemoglobin that transports oxygen in muscles and which provides much of the visual appearance of color in muscles. The absorption spectrum of myoglobin is different from oxy- and deoxyhemoglobin. This difference can be used to differentiate hemoglobin contained within vessels from myoglobin in vessel walls, muscle or other tissue, thus producing good blood-tissue contrast. Note that extravascular blood will not optically change in a pulsatile fashion as will blood in arteries (and to a lesser extent, veins), thus the aforementioned pulsatile imaging scheme can be used to differentiate intervascular blood from extravascular blood.
- Confocal Enhanced Imaging
- The concept of rejecting light scattered from locations other than the point being imaged (that is, with coordinates x,y,z), by using apertures in the imaging system, is referred to as confocal imaging. This concept has been used to “optically section” microscopic specimens being viewed with a microscope. Confocal microscopy normally uses white light illumination, or ultraviolet to green illumination to induce fluorescence in the sample. The former illumination results in significant chromatic aberrations in the final image, while the latter provides only a fluorescent image.
- It would be beneficial, in certain cases, to use red and/or near infrared radiant energy in a confocal imaging optical system, along with white-light illumination. Narrow band illumination through the use of diode lasers or bandpass filtered broadband light sources would be optimal (
FIG. 2 ). By alternately illuminating the region-of-interest (ROI), for example, 660 nm and 940 nm radiant energy in a confocal imaging system, it would be possible to collect information on HbO2 and Hb as well as information as a function of depth in the sample. Illumination at these wavelengths could be alternated with illumination using white light so that a normally appearing image of the region-of-interest would also result. This could allow one to visualize blood vessels, for example, below other normally appearing intervening structures that reduce or eliminate the ability to visualize the vessels. - Raman Enhanced Imaging
- Raman spectroscopy is a light scattering technique that uses (typically) laser radiation to excite the sample, whereby the scattered radiation emitted by the sample is analyzed. Emission data has two main characteristics: the frequencies at which the sample emits the radiation (a small number of the incident photons, perhaps only 1 in 106, is emitted at frequencies different from that of the incident light), and the intensities of the emissions. Determining the frequencies allows identification of the sample's molecular makeup, since chemical functional groups are known to emit specific frequencies and emission intensity is related to the amount of the analyte present. Now, with highly sensitive imaging light detectors (e.g. CCDs) and efficient optics such as transmission holographic gratings and notch filters, Raman spectroscopy has seen a resurgence of interest in the medical field.
- It would be useful to illuminate the anatomic structure of interest with the radiant energy produced by, for example, a 850 nm diode laser, and to use a Raman spectrograph for imaging (
FIG. 3 ). The Raman scattered photons specific to Hb and/or HbO2 could then be used to detect and discriminate blood from other tissues made of different biomolecules. Of course, the same idea can be extended to other biomolecular species of interest such as circulating pharmaceuticals, liver enzymes and glucose. To build up an image using Raman scattered photons, it may be necessary to either scan the collimated and focused illuminating light beam in a raster-scan, for example, and capture information point-by-point so that a two-dimensional image can be made up. Alternatively, the detector (if it is not an imaging type) can be scanned. Still alternatively, a two-dimensional imaging detector, such as a CCD, can be used. In any case, the strong molecular specificity of Raman scattering would allow for good rejection of signals not pertaining to the molecule of interest. - Laser Speckle Enhanced Imaging
- If the movement and/or texture of objects reflecting coherent laser radiant energy have dimensions on the order of the wavelength of the radiant energy, then constructive and destructive interference can take place. To the eye, this can give the appearance of a “speckle” pattern superimposed on the illuminated object. If the object reflecting the laser light moves with respect to the incident laser beam, then the speckle pattern moves. Such movement can be used to detect motion. This concept could beneficially be used to detect blood flow. Sometimes the tissue overlying a blood vessel moves slightly as a result of pulsatile blood flow. For example,
FIG. 4 shows an imaging system being used to detect blood within a vessel. The imaged vessel and surrounding structures are illuminated with radiant energy produced by a laser, preferably in the near infrared region of the spectrum so relatively deep penetration of the radiant energy occurs, and yet is reflected from red blood cells (RBC); for example, 805 nm light. The reflected radiant energy can be captured by a detector, which is positioned behind an aperture. Thus, any change in the speckle pattern results in a change in the detector's signal output. Any changing speckle pattern is a consequence of RBC movement. If the infrared laser is scanned, then an image of the speckle pattern can be built up and spatially dependent RBC movement can be detected, thus providing a means with which to detect blood vessels. Again, a normally appearing image using white-light illumination could be captured and the blood-vessel movement information could be superimposed on the image. - Multiphoton Interaction Enhanced Imaging
- Under certain irradiation conditions, it is possible to have photons, with a wavelength λ, interact with an atom or molecule which normally would not absorb at λ, but which does absorb at a different λ. For example, fluorescein which has an absorption peak around 500 nm can be induced to fluoresce when irradiated with two photons with a wavelength of 1000 nm, that arrive virtually simultaneously. Three-photon excitation can also be used in certain circumstances, but in this case the wavelength of the photons must be ⅓ that of the wavelength of absorption. This multi-photon effect requires lasers which produce high peak powers (e.g. >2 kW in a pulse length, τp<1 ps) and yet have a low average power so that there are no undesirable laser-tissue interactions such as photothermal coagulation. This multi-photon effect can be used for fluorescence imaging as the requisite high photon density can be made to occur only at the focus of the laser beam, which can then be scanned in three dimensions. The benefits of multi-photon excitation is that the incident radiant energy is not attenuated by absorption of the fluorochrome above the plane of focus and the longer excitation wavelengths used are less Rayleigh scattered.
- It is generally believed that multi-photon techniques are useful only for fluorescence imaging. However, it is known that the scattering and absorption effects of tissue are related to each other by a mathematical relation from classical electromagnetic theory. Thus, in the electromagnetic spectrum where tissue is highly absorbing, it is also highly scattering. Thus, a multiphoton effect can be used to gather absorption and scattering imaging information. For example, considering that blood absorbs strongly at about 400-425 nm, however radiant energy with this wavelength (which appears blue) is so strongly absorbed in tissue that it only penetrates superficially. However, it is possible with two-photon scattering and absorption to obtain information about blood using radiant energy at 800-850 nm. Such radiant energy is quite penetrating in tissue, and yet will interact with blood if the photon density per unit time is large enough. It is therefore possible to obtain imaging information (
FIG. 5 ) using a pulsed laser producing near infrared radiant energy. For practical reasons, such an imaging scheme may benefit from using a Q-switched Nd:YAG laser (1064 nm), as such lasers are relatively inexpensive and fortuitously blood absorbs strongly at 532 nm. The 532 nm scattered information could be collected in synchrony with the pulsed Nd:YAG laser. On alternate scans, white light or infrared images could be captured. Comparison of the two could be used to determine the location of the blood (or other light absorbing/scattering chromophore) in the field of view. - Optical Coherence Tomography Enhanced Imaging
- Optical coherence tomography (OCT) is based on low-coherence interferometry (e.g. white-light Michelson interferometry). High resolution depth-dependent imaging is obtained by focusing light from an optical low coherence source (e.g. LED) on the biological tissue and interfering the backscattered intensities with the incident light (
FIG. 6 ). Images in the first two dimensions are obtained by performing the interferometric measurement as a function of transverse (x,y) positions in the tissue. Third dimension (depth) information in the tissue is collected by varying the reference arm pathlength axially (z position) in the interferometer. Useful interferometric information occurs only when the optical pathlengths of the light traversing the reference path and tissue path are identical to within the coherence length of the source. Optical coherence tomography is beneficial in that is does not require an illumination source with a long coherence length (e.g. a laser) and can be done with the use of optical fibers. - It would be beneficial to use optical coherence tomography with infrared radiant energy to obtain good penetration of the light. By using several wavelengths of light sequentially, in the same manner described for the pulsatile enhanced imaging scheme described previously, specific images of arteries and veins could be obtained, as well as a non-invasive measurement of blood oxygen saturation in a particular imaged vessel.
- Time Correlated Single Photon Counting Enhanced Imaging
- Time-correlated single-photon counting (TCSPC) is a statistical technique which may be used to measure the time profile of the emission of a sample following excitation by a short light pulse. The time delay between a trigger (“start”) pulse, which is fixed in time with respect to the excitation pulse, and the moment of arrival of a photon emitted by the sample and then detected by a photomultiplier (“stop” pulse) is recorded. By accumulating many such intervals in a histogram, the probability that a photon is emitted by the sample at a certain moment is measured, i.e., the time profile of the emission is measured.
- Time-correlated single-photon counting is a commonly used technique in fluorescence spectroscopy due to its wide dynamic range, high time resolution and high sensitivity. Time resolutions of the order of 50 ps (FWHM) are easily achievable with commercial ultrafast laser and detector systems. Typically, a mode-locked argon-ion laser is used to synchronously pump a cavity-pumped dye laser. The resultant train of picosecond pulses may be coupled into an optical fiber in contact with the sample under investigation. The pulse shape changes as it propagates through the medium. This is due to the fact that photon pathlengths are altered through interactions (scattering and absorbing) with the medium. In fact, the optical properties of the medium may be inferred from the shape of the emitted pulses. Typically, the emitted pulses are collected with an optical fiber positioned on the sample at a known distance from the input fiber. The distal end of the collection fiber is in contact with the detector, which, for ultrafast applications, is a microchannel plate-photomultiplier tube (MCP-PMT).
- The optical properties (scattering and absorption) of the material may be obtained through non-linear least squares fitting of the data (amplitude vs. time spectra) to a model function. A diffusion model is commonly used to fit the data. Analytic solutions of the diffusion equation in homogeneous media exist for various simple geometries. This data (absorption and scattering coefficients) can be collected during scanning in the x-y plane in order to build up an image. Depth z dependent information could be obtained using one of the depth discriminate techniques, such as OCT or confocal, described above.
- Optical Rotatory Dispersion, Circular Dichroism and Polarization Enhanced Imaging
- Circular dichroism (CD) and optical rotatory dispersion (ORD) are polarization dependent measurements whereby circular dichroism measures a difference between the absorption in matter of radiant energy that is left and right circularly polarized light, while optical rotatory dispersion measures the difference in the refractive indices for left (L) and right (R) circularly polarized light. If a biomolecule is optically active, i.e., if dissymmetric and non-superimposable mirror images of the molecule occur, circularly polarized light interacts with the molecule depending on the handedness of the light. Molecular shape and orientation also determines the degree to which linearly polarized light interacts with a molecule. For example, polarizing sunglasses have absorbing chromophores that are mostly oriented horizontally; thus when light specularly reflected from a roadway (which is, to a degree, linearly polarized with the axis of polarization oriented horizontally), then it is absorbed by the chromophores. Unpolarized light retroreflected from a tissue interface will have a degree of linear polarization; incident linearly polarized light retroreflected (
FIG. 7A ) from deeper within the tissue will loose the initial polarization, depending on how many scattering events occur within the tissue; the more scattering events that photon experiences, the more the polarization becomes random with respect to the polarization of the injected photon. - These ideas can be used to improve the ability to image subsurface anatomic structures. For example, specular reflectance from tissue interfaces, which can tend to obscure the image of a subsurface structure, can be reduced or eliminated by linearly polarizing the incident light, and incorporating a linear analyzer whose transmission axis is oriented orthogonal to the transmission axis of the incident light polarizer. Similarly, by passing unpolarized light through a linear polarizer and a wave retarder, circularly polarized light is produced which, when retroreflected, will be absorbed upon passing through the same wave retarder and linear polarizer (
FIG. 7B ). Note that these polarization techniques which serve to reduce unwanted specular reflection can also be used to increase the ratio of photons scattered once or a few times (i.e. superficially penetrating photons) to photons scattered many times (i.e. deeper penetrating photons). Thus this serves as a way to either reject highly scattered photons which serve to degrade image contrast, or to get depth discriminate information. - These same methods can be used for molecular discrimination. Note that devices to measure the reflectance and absorbance from tissue of polarized light, and the state of polarization in the reflected light, can make use of a photoelastic modulator (PEM), which is a device that, depending on the waveform and phase driving it, can be used to analyze polarized light when used in conjunction with polarizers and waveplates. The frequency at which the PEM is driven, and the frequency of signal detected, also play a role in determining what exactly is being measured (Hinds Instruments, Inc., Oregon).
- For example, optically active molecules such as glucose can be detected by transmission measurements using CD or optical rotatory dispersion. PM-IRRAS stands for Polarization Modulation Infrared Reflection-Absorption Spectroscopy. It is the differential IR absorption between the s- and p-linearly polarized light for the molecules in a tissue (
FIG. 7C ). In ellipsometry, the polarization change of a light beam is measured when it is reflected by the sample. This change in polarization is then related to the sample's properties (FIG. 7D ). Vibrational circular dichroism (VCD) is the differential absorption between left and right circularly polarized light. It is a measurement of the optical activity for chiral molecules (FIG. 7E ). Linear dichroism (LD) is the differential absorption between two orthogonal, linearly polarized states. Linear dichroism is a measurement of the sample's bulk property that is a result of the regular orientation of the molecules in the sample (FIG. 7F with the PEM set at 0° and phase-sensitive detector at the 2nd harmonic). - Image Processing
- Image processing devices, which can manipulate digital image data quickly, would be beneficially used in any of the above methods. For example, Hamanatsu Photonic Systems (Bridgewater, N.J.)) sells a unit which can perform real-time edge enhancement, uneven illumination compensation and frame averaging. Alternatively, with the advent of extremely fast video processing hardware, it is possible to perform mathematical operations on the video signals in real-time thereby allowing various enhancement schemes. For example, a Fast Fourier Transform can be performed on the video image, and edge enhancement can be done by high-pass filtering the transform prior to performing the inverse Fast Fourier Transform. One very important post-processing algorithm involves pixel-stretching, whereupon the contrast of a low contrast image is increased by altering the video image pixel values to utilize the full spread of values (e.g. 256) available in the digitizer. As the region-of-interest (ROI) is typically unevenly illuminated, it would be beneficial to be able to select an ROI on the video monitor, perhaps through the use of a mouse, and to apply the image processing algorithms to that region only. This would maximize the contrast in the region-of-interest and would allow the user to ignore other unimportant information which may be very dark or very light, and so can make automated image processing of the full image difficult.
- Vascular Contrast Enhancement
- In order to improve the imaging contrast between blood vessels, or other sub-surface structures, and the surrounding tissue, it may be beneficial to use exogenous chromophores. For example, Indocyanine Green (ICG) is a well know agent which has been used for many years in quantifying cardiac output and imaging retinal vasculature. When dissolved in plasma, it has an absorption maximum at about 800 nm. By employing multiple-wavelength illumination and/or detection whereby one of the images captured was illuminated or detected around 800 nm, and the other at a wavelength where indocyanine green is only weaking absorbing (say, for example, 660 nm), then it is possible to differentially image vasculature. However, when combined with the aforementioned pulsatile imaging methodology, for example, further contrast enhancement will be achieved. This same idea of using exogenous chromophores can be extended with a range of other molecules, some of which have a beneficial tendency of concentrating in diseased tissue. For example, it is know that δ-aminolevulinic acid (δ-ALA) preferentially collects in malignant tissue where it greatly enhances the production of porphyrins. These porphyrins are strongly absorbing and fluorescent, and so this compound combined with the above discussed imaging techniques can be used to identify (and actually treat) cancer.
- It could be of importance to provide good contrast between such things as endoscopes, fingertips, other surgical components, etc., in the infrared image. Carbon and graphite, for example, are strong absorbers of near infrared radiant energy. By coating gloves, instruments, etc, in a thin layer of these materials would appear dark in an infrared imaging system.
- Alternating Color and Infrared Imaging and Rapid Sequential Image Display
- Most surgeons are most familiar with endoscopic images obtained using white-light illumination and color sensitive cameras. Color information is also used by the surgeon for diagnostic information (e.g. detecting erythema or malignancies). On the other hand, infrared sensitive cameras produce only a black-and-white (B & W) image. It would be beneficial to devise an imaging system whereby the surgeon can either select to quickly change from color to B & W imaging, or to collect the most relevant infrared image information (for example, the location of a subsurface blood vessel) and to superimpose this information on the color image. Another way to achieve the same thing is to use an infrared sensitive CCD detector, in front of which is positioned a rotating filter wheel with red, green, blue and infrared bandpass filters. The filters are positioned in front of the CCD at a known rate and in synchrony with the capture of information from the CCD. The information can then be processed into an infrared image and into a color image (by combining the red, green and blue information).
- Another way to enhance the visual appearance of blood vessels in these images is to use a process sometimes referred to, by astronomers, as “blink” imaging. The eye (and brain) are apparently quite sensitive to small changes in the appearance of a visual field, more so than small differences in a static field. It would therefore be beneficial to configure the image processing and display system such that the image would switch rapidly (e.g. 2 Hz) between a white-light illuminated black-and-white or color image and the infrared image. This mode of display would serve to enhance the visualization of the blood vessels.
- Combining with Therapeutic Laser Energy Delivery Devices
- Optical fibers can be used to guide the radiant energy of a laser down an endoscope, whereupon it is used to cut, coagulate, or induce fluorescence in tissue. It would be beneficial in certain surgeries, such as third ventriculostomy, to be able to use infrared imaging to identify sensitive subsurface structures such as blood vessels, and then to use the radiant energy produced by a laser (the 2.94 micron wavelength radiation produced by an Er:YAG laser, for example) to produce a fenestration in the membrane (floor of the third ventricle). The use of the imaging technology in conjunction with therapeutic laser radiant energy would be important clinically.
- Coherent Imaging Fiber Bundle
- Some of the embodiments of the inventions described will be too bulky to mount on devices that can be easily manipulate by the health-care provider. It might therefore, in certain cases, be beneficial to optically guide the image from a small handpiece over to the image collection and processing device, which could be positioned on a table nearby. Coherent imaging fiber bundles are suitable for this purpose. The input end of the bundle is positioned in the image plane of an optical system directed at the ROI, and the output end of the bundle is positioned in the object plane of the image collection system. This arrangement is light and flexible, thus, gives the health-care provider necessary freedom-of-movement.
- Magnification
- Making use of magnification would be a useful addition to the imaging device in many instances. For example, blood vessels in babies are very small and quite difficult to see. Small, telangiectasia vessels are also difficult to see during treatment. The combination of the image contrast improving methods described herein and optical magnification would serve to improve clinical efficiency during blood vessel puncture procedures or treatment of diseased blood vessels.
- Infrared Transillumination
- The illumination systems used in the described applications can also be applied as transilluminators. When a beam of light is held against tissues, such as skin or mucous membranes, whether applied externally or internally, much of the light scatters through the tissues and illuminates the area beneath the skin and laterally. This scattered light illuminates tissue structures in proximity to the site where the photons are injected. By using an infrared sensitive detector and infrared incident light or light which has an infrared component, it is possible to observe subsurface anatomic structures such as blood vessels beneath the skin.
- Heads-Up and Projection Display
- It is typical that the health-care provider needs to keep both hands free for procedures, therefore, any imaging system that is most beneficial is the one that does not need to be hand-held or manipulated. Furthermore, it is of benefit that the imaging system is possible to simultaneously view the actual region of interest on the patient, if it is required that the image of the ROI needs to be displayed for the provider.
- In one embodiment of the invention, the video information could be inputted into a video projector whereupon the image of the ROI is projected back onto the actual ROI on the patient. The projected image could be enhanced so that the structures of interest (typically blood vessels) are made as contrasty as possible and the rest of the image is made uniform. Thus the projection would serve to outline the actual position of the structures on the patient, thus enhancing the ease with which they are manipulated b y the health-care provider. Another way to achieve a similar effect is to project the video image onto a partial reflecting screen which reflects the image back to the provider; the subject is positioned on the opposite side of the screen so that the video image appears to the provider to be superimposed on the actual subject. This form of display is similar to that used in fighter-aircraft and is sometimes called a heads-up-display.
- Illumination Compensation
- As the dynamic range of CCD video cameras is much less than the human eye, displaying all of the structures of interest in an unevenly illuminated ROIs can be problematic. This problem will be minified by using a camera with a greater dynamic range, such a s tube-type cameras. Alternatively, another solution to this is to either tailor the light field to compensate for an uneven topography in the ROI, or to adjust the gain of the CCD pixels non-uniformly. For example, in the case of the former, the addition of anodized mask over the illumination source that has, to a first approximation, a spatially dependent transmittance that is similar to the shape of the ROI (
FIG. 8 ). Another way to achieve the same effect is to control the gain in each pixel of the CCD individually, instead of the typical way whereby they are adjusted together. For example, the health-care provider could outline an ROI on a video screen with a mouse, and the computer to which the screen is interfaced could then direct information to the CCD video camera such that the gain of the relevant pixels are adjusted, and the rest of the pixels in the image are ignored. A similar sort of non-uniform gain is used in, for example, the Hamamatsu C2400-1 controller which allows the user to adjust the gain of the CCD in four quadrants of the image by adjusting four potentiometers. - Intravascular Versus Extravascular Blood Discrimination
- One problem in surgery and endoscopic surgery is when bleeding occurs, the pooling blood can inhibit the surgeon from visualizing what is below. Unfortunately, this often makes ligating or cauterizing the bleeding vessel difficult to do. The blood flowing out of a vein or artery has a pulsatile flow which is related to the heart beat. The blood pooling in and around the bleeding tissue does not have a pulsatile flow, but instead flows at a steady rate, if at all. Therefore, using the aforementioned pulse imaging concepts would allow the surgeon to remove from an image the absorption due to static blood, and yet still provide imaging information of vascular blood and tissue. In this case, since it may be necessary to differentiate between HbO2, Hb, and Mb, either three different wavelengths of illumination will be necessary, or a rotating filter wheel with three filters may be required.
- Varicose Veins
- Treatment of varicose veins can be problematic in that accurately imaging the vein before and during the procedure can be difficult. Loss of blood from the vein or presence of extravascular blood can further obscure the veins during procedures. The infrared imaging technology described herein would be useful during the therapeutic processes (e.g. vein stripping, laser irradiation, sclerotherapy, etc.) by allowing the surgeon to visualize the vessels accurately (
FIG. 9 ). This device could have a plurality of support arms which serve to allow placement of the device on the patient thus freeing the hands of the surgeon. Alternatively, the device could be positioned on a support employing a ball joint such that it could be positioned in any way by the surgeon and will be kept in that position. The support arms could have incorporated an optical wave guide, such as an optical fiber bundles, which transmits illumination from the source to the surface of the skin. The arms terminate in an infrared filter and optionally a polarizing filter. The light will be directed out of the terminal portion of the arms either perpendicularly to the skin surface, or at an oblique angle directed into the ROI. A video camera can be affixed to the light source such that it images the ROI; the output of the camera is conducted through a cable to the video controller and/or monitor. - In a related surgical strategy, following localization of the vessels by these and other methods not described here, varicose veins may be treated by intraluminal insertion of an optical fiber which guides laser radiant energy (e.g. Nd:
YAG 1064 nm radiation) into the vessel and inducing coagulation. This procedure would further be improved as the fiber could be coated in an infrared absorbing agent (such as ICG) whereby it could be imaged with the technology discussed herein. - Endoscopic Surgery
- Endoscopic surgery, such as a third ventriculostomy, would benefit from the technology described herein. It is always important for the endoscopic surgeon to avoid dissecting blood vessels during insertion and advancement of the endoscope. The infrared imaging technology and other blood discrimination techniques described herein would be of benefit in allowing the endoscopist to avoid such vessels.
- Localizing Blood Volumes for Analytical Spectral Measurements
- Measuring analyte levels in blood or other tissues with minimally invasive techniques is a very desirable objective. A problem encountered during optical spectral measurements of blood analyte levels is the inability to measure the volume of tissue interrogated. This problem is further compounded by the fact that differences may exist between analyte concentrations extravascularly versus intravascularly. These differences may be difficult to differentiate, resulting in skewed values. The vessel imaging technology described herein allows for the blood in a vessel to be identified. In other words, the blood can be located. Thus, in effect, a virtual optical isolation of a volume of blood may be performed. Once the volume is isolated in this way, the available spectral analysis techniques could be further employed to obtain the information of interest regarding analyte concentration, or regarding any blood disorders that are characterized by unique spectral shifts.
- Disposables
- To maintain sterility or at least to keep anything from being positioned near or on a patient, it would be beneficial to employ a disposable shield in many of the aforementioned methods such that any biological material (blood, saliva, ablated tissue, etc.) could not contaminate the imaging process. For example, a disposable plastic sheath that covers the objective lens, scanner and/or camera of the imaging system would be useful. The contact probe illustrated in
FIG. 9 could itself be disposable. Alternatively, disposable plastic sheaths could be also employed on each of the components that actually touches the patient. - An infrared sensitive CCDvideo camera (e.g. Hamamatsu C2400-79, Hamamatsu Photonic Systems, Bridgewater, N.J.) and an image processing and analysis system (Hamamatsu Argus-20) are coupled together. A 250 W quartz incandescent light source is optically coupled into a light transmitting fiber bundle which is coupled to an endoscope (e.g. Smith & Nephew Dyonics No. 3626S focusing video arthroscope). The proximal end of the endoscope is connected to a custom-made coherent fiber optic bundle (Schott Fiber Optics, MA) which carries the imaging information to the infrared camera. Between the fiber bundle and infrared camera is located an infrared long-pass filter (e.g. Edmund Scientific RG715 glass filter, Edmund Scientific, Barrington, N.J.). A macrolens on a c-mount, attached to the CCD camera, is used to image the end of the fiber bundle. The image processing unit is set to enhance edges and frame average in order to minimize the appearance of noise in the image.
- An infrared sensitive CCD video camera (e.g. Dage-MTI CCD 300) was fixed with a 19-38 mm zoom lens and the output was sent to a standard video monitor. An optical infrared long-pass filter (Edmund Scientific, Inc.) was positioned in front of the lens of the video camera. The device was used to image the varicose veins of a patient undergoing surgical removal of the veins. The (epi-) illumination was optionally a 30 W quartz camcorder light source, which had a Kodak Wratten No. 29 (red) gelatin filter placed in front of the source, or a white-light source (Smith and Nephew, Inc.) connected to an endoscope, which was interstitially positioned within the patient's leg below the varicose veins in order to provide back-illumination of the veins. During this experiment, it was determined that the greatest vein-tissue contrast was achievable when the black-level control on the CCD camera controller was minimized, and the gain was then adjusted in order to obtain a visible image on the video monitor. The veins were imaged well with either interstitial transillumination, or red-filtered epi-illumination. It was also determined that by using an oblique (non-normal) viewing angle and/or oblique illumination angle, the contrast of the blood vessels was enhanced.
- Any patents or publications mentioned in this specification are indicative of the levels of those skilled in the art to which the invention pertains. These patents and publications are herein incorporated by reference to the same extent as if each individual publication was specifically and individually indicated to be incorporated by reference.
- One skilled in the art will readily appreciate that the present invention is well adapted to carry out the objects and obtain the ends and advantages mentioned, as well as those inherent therein. The present examples along with the methods, procedures, treatments, molecules, and specific compounds described herein are presently representative of preferred embodiments, are exemplary, and are not intended as limitations on the scope of the invention. Changes therein and other uses will occur to those skilled in the art which are encompassed within the spirit of the invention as defined by the scope of the claims.
Claims (31)
1. A method of optically imaging subsurface anatomic structures and biomolecules in an individual or animal with red light and infrared radiant energy, comprising the steps of:
illuminating a region of interest with light from the red to radiant infrared portion of the light spectrum; and,
detecting red and infrared light from said region of interest with a red and infrared light sensitive image detector.
2. The method of claim 1 , wherein said region is illuminated with light energy having wavelengths ranging from 600 nm to 1100 nm.
3. The method of claim 1 , wherein said infrared sensitive image detector detects red and infrared light selected from the group consisting of transmitted light, reflected light, absorbed light, and emitted light.
4. The method or claim 1 , wherein said light is detected by a method selected from the group consisting of pulsatile enhanced imaging, confocal enhanced imaging, Raman enhanced imaging, laser speckle enhanced imaging, multiphoton interaction enhanced imaging, optical coherence tomography enhanced imaging, time correlated single photon counting enhanced imaging, optical rotary dispersion imaging, circular dichroism imaging, and polarization enhanced imaging.
5. The method of claim 1 , wherein images from said infrared sensitive image detector are displayed on a video monitor.
6. The method of claim 1 , further comprising the step of adding an exogenous chromophore to the region of interest.
7. The method of claim 6 , wherein said chromophore is selected from the group consisting of indocyanine Green (ICG) and δ-aminolevulinic acid
8. A device for performing the method of claim 1 , said device comprising:
a red to radiant infrared light source;
a red and infrared sensitive image detector; and,
a means to display detected images.
9. The device of claim 8 , wherein said light is provided by a source selected from the group consisting of light-emitting diodes (LEDs) filtered with a bandpass filter, diode lasers and filtered broadband illumination.
10. The device of claim 8 , wherein said detector is selected from the group consisting of a charge-coupled device (CCD) and a CCD video camera.
11. A method of optically imaging subsurface anatomic structures and biomolecules by pulse oximetry, comprising the steps of:
illuminating a region of interest with alternating wavelengths of light from the red to radiant infrared portion of the light spectrum; and,
detecting red infrared light from said region of interest with a pulse oximeter.
12. The method of claim 11 wherein said method is used to detect blood in said region of interest.
13. The method of claim 12 , wherein said region of interest is illuminated with red light of 660 nm wavelength and infrared light of 940 nm wavelength.
14. The method or claim 12 , wherein imaging of arterial and non-arterial blood is differentiated by discriminating between time-varying signals and non-varying signals.
15. The method of claim 12 , wherein an electrocardiogram (ECG) electrode is used to monitor a heartbeat in order to match the phase of the signal with the heartbeat.
16. The method of claim 12 , comprising the further step of using pulse oximetry data to determine the oxygen saturation of said blood.
17. The method of claim 11 , wherein illumination is performed with multiple wavelengths of radiant energy to achieve enhanced imaging contrast.
18. The method of claim 17 , wherein said enhanced imaging contrast is used to distinguish between hemoglobin within blood vessels versus extravascular hemoglobin.
19. The method of claim 17 , wherein said enhanced imaging contrast is used to distinguish between myoglobin, oxyhemogloblin and deoxyhemoglobin to obtain blood-tissue contrast.
20. A device for performing the method of claim 11 , comprising,
a source of red to radiant infrared light of alternating wavelengths;
an red and infrared sensitive image detector; and,
a means to display detected images.
21. The device of claim 20 , wherein said light is provided from a broadband source and said detector is a camera fitted with a rotating filter wheel.
22. A method of obtaining depth specific information when optically imaging subsurface anatomic structures and biomolecules, comprising the steps of:
illuminating a region of interest with narrow bands of light from the red to radiant infrared portion of the light spectrum; and,
detecting red and infrared light from said region of interest by confocal imaging.
23. The method of claim 22 , comprising the further step of alternating red illumination with white light illumination so that a normal image of the region-of-interest is obtained.
24. The method of claim 22 , wherein said region of interest is alternatively illuminated with radiant energy of 660 nm and 940 nm wavelengths to collect information on oxyhemoglobin and deoxyhemoglobin as a function of depth.
25. A device for performing the method of claim 22 , comprising,
a source of red to radiant infrared light;
an infrared sensitive confocal image detector; and,
a means to display detected images.
26. A method of optically imaging the location of a specific biomolecule in subsurface anatomic structures by Raman spectroscopy, comprising the steps of:
illuminating a region of interest with a single wavelength of light from the red to radiant infrared portion of the light spectrum; and,
using Raman spectrosopy to detect frequencies and intensities of light emitted from said region of interest, wherein frequencies are specific to given biomolecules and intensities are indicative of the amount present;
analyzing said data as a function of location to construct a two or three dimensional image of the distribution of a detected biomolecule.
27. The method of claim 26 , wherein said region of interest is illuminated with light from an 850 nm diode laser.
28. A device for performing the method of claim 26 , comprising,
a source of red to radiant infrared light;
a Raman Spectroscope; and,
a means to process and display detected images.
29. A method of using laser speckle imaging to detect movement when optically imaging subsurface anatomic structures and biomolecules, comprising the steps of:
illuminating a region of interest with coherent laser light in the red to radiant infrared portion of the light spectrum;
detecting a “speckle” pattern of light reflected from said region of interest with a sensitive detector; and,
monitoring movement said “speckle” pattern to detect movement.
30. The method of claim 29 , wherein said movment is blood flow.
31. A device for performing the method of claim 29 , said device comprising:
a red to radiant infrared coherent laser light source;
a red and infrared sensitive image detector; and,
a means to display detected images.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/036,548 US20050143662A1 (en) | 2000-05-03 | 2005-01-14 | Optical imaging of subsurface anatomical structures and biomolecules |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US20159200P | 2000-05-03 | 2000-05-03 | |
US09/848,596 US6889075B2 (en) | 2000-05-03 | 2001-05-03 | Optical imaging of subsurface anatomical structures and biomolecules |
US11/036,548 US20050143662A1 (en) | 2000-05-03 | 2005-01-14 | Optical imaging of subsurface anatomical structures and biomolecules |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/848,596 Division US6889075B2 (en) | 2000-05-03 | 2001-05-03 | Optical imaging of subsurface anatomical structures and biomolecules |
Publications (1)
Publication Number | Publication Date |
---|---|
US20050143662A1 true US20050143662A1 (en) | 2005-06-30 |
Family
ID=22746451
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/848,596 Expired - Fee Related US6889075B2 (en) | 2000-05-03 | 2001-05-03 | Optical imaging of subsurface anatomical structures and biomolecules |
US11/036,548 Abandoned US20050143662A1 (en) | 2000-05-03 | 2005-01-14 | Optical imaging of subsurface anatomical structures and biomolecules |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/848,596 Expired - Fee Related US6889075B2 (en) | 2000-05-03 | 2001-05-03 | Optical imaging of subsurface anatomical structures and biomolecules |
Country Status (3)
Country | Link |
---|---|
US (2) | US6889075B2 (en) |
AU (1) | AU2001259435A1 (en) |
WO (1) | WO2001082786A2 (en) |
Cited By (77)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040082863A1 (en) * | 2002-03-15 | 2004-04-29 | Mcgreevy James | Device and method for the photodynamic diagnosis of tumor tissue |
US20050131284A1 (en) * | 2002-04-02 | 2005-06-16 | Yeda Research And Development Co. Ltd. | Characterization of moving objects in a stationary background |
US20060004292A1 (en) * | 2002-12-13 | 2006-01-05 | Alexander Beylin | Optical examination method and apparatus particularly useful for real-time discrimination of tumors from normal tissues during surgery |
US20060250613A1 (en) * | 2005-04-14 | 2006-11-09 | Chem Image Corporation | Method and applications to enhance and image optical signals from biological objects |
US20070027362A1 (en) * | 2005-07-27 | 2007-02-01 | Olympus Medical Systems Corp. | Infrared observation system |
US20070161907A1 (en) * | 2006-01-10 | 2007-07-12 | Ron Goldman | Micro vein enhancer |
US20070293766A1 (en) * | 2004-08-27 | 2007-12-20 | Koninklijke Philips Electronics N.V. | Transmission Based Imaging for Spectroscopic Analysis |
US20080004525A1 (en) * | 2006-01-10 | 2008-01-03 | Ron Goldman | Three dimensional imaging of veins |
US20080027317A1 (en) * | 2006-06-29 | 2008-01-31 | Fred Wood | Scanned laser vein contrast enhancer |
US20080045818A1 (en) * | 2006-06-29 | 2008-02-21 | Fred Wood | Laser vein contrast enhancer |
US20080177184A1 (en) * | 2006-06-29 | 2008-07-24 | Ron Goldman | Micro vein enhancer |
WO2008112312A1 (en) * | 2007-03-14 | 2008-09-18 | Geneva Medical Imaging, Llc | Apparatus and method for phase-space reduction for imaging of fluorescing, scattering and/or absorbing structures |
US20090002488A1 (en) * | 2007-06-28 | 2009-01-01 | Vincent Luciano | Automatic alignment of a contrast enhancement system |
US20090054767A1 (en) * | 2007-03-14 | 2009-02-26 | Nicholas Alexander Telischak | Surgical method and apparatus for identification of fluorescence |
US20090123045A1 (en) * | 2007-11-08 | 2009-05-14 | D4D Technologies, Llc | Lighting Compensated Dynamic Texture Mapping of 3-D Models |
US20090143671A1 (en) * | 2007-12-03 | 2009-06-04 | Fujifilm Corporation | Position identifying system, position identifying method, and computer readable medium |
US20090141853A1 (en) * | 2007-11-30 | 2009-06-04 | Veronica Crews | Protective shield for ct scanning machine |
US20090221912A1 (en) * | 2005-05-06 | 2009-09-03 | Darin Nelson | Imaging and analysis of movement of erythrocytes in blood vessels in relation to the cardiac cycle |
US20100056936A1 (en) * | 2006-12-01 | 2010-03-04 | Hitoshi Fujii | Blood flow rate imaging device |
US20100121200A1 (en) * | 2007-04-19 | 2010-05-13 | Institut De Radioprotection Et De Surete Nucleaire | Diagnostic and prognostic assistance device for physiopathological tissue changes |
US20100166650A1 (en) * | 2007-05-04 | 2010-07-01 | Gambhir Sanjiv S | Molecular imaging of living subjects using raman spectroscopy and labeled raman nanoparticles |
US20110038511A1 (en) * | 2002-05-09 | 2011-02-17 | Sony Corporation | Compact biometric authentication device and associated methodology of imaging and detecting living-tissue patterns |
US20110063617A1 (en) * | 2008-04-04 | 2011-03-17 | Hiromi Takahashi | Method and Device for Measuring Circular Dichroism Spectra |
US20110112407A1 (en) * | 2006-06-29 | 2011-05-12 | Fred Wood | Multispectral detection and presentation of an object's characteristics |
US20110118611A1 (en) * | 2006-06-29 | 2011-05-19 | Vincent Luciano | Module mounting mirror endoscopy |
US20110125028A1 (en) * | 2009-07-22 | 2011-05-26 | Fred Wood | Vein scanner |
US20120062897A1 (en) * | 2010-09-13 | 2012-03-15 | Stavros Demos | Enhancement of the visibility of objects located below the surface of a scattering medium |
US20120120245A1 (en) * | 2010-11-15 | 2012-05-17 | Intuitive Surgical Operations, Inc. | System and method for multi-resolution sharpness transport across color channels |
US20120162438A1 (en) * | 2009-09-04 | 2012-06-28 | The John Hopkins University | Multimodal laser speckle imaging |
WO2012109116A2 (en) * | 2011-02-07 | 2012-08-16 | Quantum Catch, Llc | Noninvasive eye-property monitoring, including aqueous-humor glucose monitoring as an indication of blood glucose level |
US20120271176A1 (en) * | 2011-04-21 | 2012-10-25 | Moghaddam Hassan Ghaderi | Method and system for optically evaluating proximity to the inferior alveolar nerve in situ |
US20120326055A1 (en) * | 2009-12-18 | 2012-12-27 | University Health Network | System and method for sub-surface fluorescence imaging |
US8403862B2 (en) | 2007-12-20 | 2013-03-26 | Yeda Research And Development Co. Ltd. | Time-based imaging |
WO2014043378A1 (en) * | 2012-09-12 | 2014-03-20 | The General Hospital Corporation | Apparatus and method for volumetric imaging of blood flow properties |
US20140187967A1 (en) * | 2012-12-05 | 2014-07-03 | Fred Wood | System and Method for Multi-Color Laser Imaging and Ablation of Cancer Cells Using Fluorescence |
US9042967B2 (en) | 2008-05-20 | 2015-05-26 | University Health Network | Device and method for wound imaging and monitoring |
US9061109B2 (en) | 2009-07-22 | 2015-06-23 | Accuvein, Inc. | Vein scanner with user interface |
WO2015117084A1 (en) * | 2014-02-03 | 2015-08-06 | The Board Of Trustees Of The Leland Stanford Junior University | Contact-free physiological monitoring during simultaneous magnetic resonance imaging |
US20160000329A1 (en) * | 2013-02-20 | 2016-01-07 | Sloan-Kettering Institute For Cancer Research | Wide field raman imaging apparatus and associated methods |
US9247876B2 (en) | 2011-03-02 | 2016-02-02 | Brien Holden Vision Diagnostics, Inc. | Ocular fundus camera system and methodology |
WO2016069086A1 (en) * | 2014-10-30 | 2016-05-06 | Bae Systems Information & Electronic Systems Integration Inc. | High definition thermal imaging for medical applications |
US9375196B2 (en) | 2012-07-12 | 2016-06-28 | Covidien Lp | System and method for detecting critical structures using ultrasound |
KR101647022B1 (en) * | 2015-02-23 | 2016-08-10 | 연세대학교 원주산학협력단 | Apparatus and method for capturing medical image |
US9451882B2 (en) | 2009-12-15 | 2016-09-27 | Emory University | Integrated system and methods for real-time anatomical guidance in a diagnostic or therapeutic procedure |
US9492117B2 (en) | 2006-01-10 | 2016-11-15 | Accuvein, Inc. | Practitioner-mounted micro vein enhancer |
KR20170009085A (en) * | 2015-07-15 | 2017-01-25 | 삼성전자주식회사 | Imaging system and mentod of laser speckle contrast and apparatus employing the same |
US9782079B2 (en) | 2012-08-02 | 2017-10-10 | Accuvein, Inc. | Device for detecting and illuminating the vasculature using an FPGA |
WO2017176781A1 (en) * | 2016-04-06 | 2017-10-12 | Laser Associated Sciences, LLC | System for blood flow measurement with affixed laser speckle contrast analysis |
US9839365B1 (en) * | 2014-11-24 | 2017-12-12 | Verily Life Sciences Llc | Applications of vasculature mapping using laser speckle imaging |
US9848787B2 (en) | 2012-02-07 | 2017-12-26 | Laser Associated Sciences, Inc. | Perfusion assessment using transmission laser speckle imaging |
US9854977B2 (en) | 2006-01-10 | 2018-01-02 | Accuvein, Inc. | Scanned laser vein contrast enhancer using a single laser, and modulation circuitry |
US10105456B2 (en) | 2012-12-19 | 2018-10-23 | Sloan-Kettering Institute For Cancer Research | Multimodal particles, methods and uses thereof |
US10238294B2 (en) | 2006-06-29 | 2019-03-26 | Accuvein, Inc. | Scanned laser vein contrast enhancer using one laser |
US10251600B2 (en) | 2014-03-25 | 2019-04-09 | Briteseed, Llc | Vessel detector and method of detection |
US10322194B2 (en) | 2012-08-31 | 2019-06-18 | Sloan-Kettering Institute For Cancer Research | Particles, methods and uses thereof |
US10413272B2 (en) | 2016-03-08 | 2019-09-17 | Covidien Lp | Surgical tool with flex circuit ultrasound sensor |
US10438356B2 (en) | 2014-07-24 | 2019-10-08 | University Health Network | Collection and analysis of data for diagnostic purposes |
US10441177B2 (en) | 2013-07-23 | 2019-10-15 | Bae Systems Information And Electronic Systems Integration Inc. | High definition thermal imaging for medical applications |
US10631838B2 (en) | 2016-05-03 | 2020-04-28 | Covidien Lp | Devices, systems, and methods for locating pressure sensitive critical structures |
US10688202B2 (en) | 2014-07-28 | 2020-06-23 | Memorial Sloan-Kettering Cancer Center | Metal(loid) chalcogen nanoparticles as universal binders for medical isotopes |
US10716508B2 (en) | 2015-10-08 | 2020-07-21 | Briteseed, Llc | System and method for determining vessel size |
US10813597B2 (en) | 2017-04-14 | 2020-10-27 | The Regents Of The University Of California | Non-invasive hemodynamic assessment via interrogation of biological tissue using a coherent light source |
US10813588B2 (en) | 2006-01-10 | 2020-10-27 | Accuvein, Inc. | Micro vein enhancer |
US10820838B2 (en) | 2015-02-19 | 2020-11-03 | Briteseed, Llc | System for determining vessel size using light absorption |
US10912947B2 (en) | 2014-03-04 | 2021-02-09 | Memorial Sloan Kettering Cancer Center | Systems and methods for treatment of disease via application of mechanical force by controlled rotation of nanoparticles inside cells |
US10919089B2 (en) | 2015-07-01 | 2021-02-16 | Memorial Sloan Kettering Cancer Center | Anisotropic particles, methods and uses thereof |
US11207024B2 (en) * | 2017-07-12 | 2021-12-28 | Boe Technology Group Co., Ltd. | Vascular imaging apparatus and vascular imaging method |
US11253198B2 (en) | 2006-01-10 | 2022-02-22 | Accuvein, Inc. | Stand-mounted scanned laser vein contrast enhancer |
US11278240B2 (en) | 2006-01-10 | 2022-03-22 | Accuvein, Inc. | Trigger-actuated laser vein contrast enhancer |
US11399898B2 (en) | 2012-03-06 | 2022-08-02 | Briteseed, Llc | User interface for a system used to determine tissue or artifact characteristics |
US11490820B2 (en) | 2015-02-19 | 2022-11-08 | Briteseed, Llc | System and method for determining vessel size and/or edge |
US11589852B2 (en) | 2016-08-30 | 2023-02-28 | Briteseed, Llc | Optical surgical system having light sensor on its jaw and method for determining vessel size with angular distortion compensation |
EP4205692A1 (en) * | 2021-12-30 | 2023-07-05 | Karl Storz Imaging, Inc. | Systems and methods for generating metamerically matched illumination |
US11696777B2 (en) | 2017-12-22 | 2023-07-11 | Briteseed, Llc | Compact system used to determine tissue or artifact characteristics |
US11711596B2 (en) | 2020-01-23 | 2023-07-25 | Covidien Lp | System and methods for determining proximity relative to an anatomical structure |
US11723600B2 (en) | 2017-09-05 | 2023-08-15 | Briteseed, Llc | System and method used to determine tissue and/or artifact characteristics |
US11961236B2 (en) | 2023-06-13 | 2024-04-16 | University Health Network | Collection and analysis of data for diagnostic purposes |
Families Citing this family (330)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070161906A1 (en) * | 2000-01-19 | 2007-07-12 | Luminetx Technologies Corporation | Method To Facilitate A Dermatological Procedure |
US20070156038A1 (en) * | 2000-01-19 | 2007-07-05 | Zeman Herbert D | Method to image the heart |
US6879713B1 (en) * | 2000-06-23 | 2005-04-12 | Women & Infants Hospital Of Rhode Island | Meiotic spindle imaging in oocytes and uses therefor in in vitro fertilization |
WO2002028273A2 (en) * | 2000-10-06 | 2002-04-11 | Yang Victor X D | Multi-spectral fluorescence imaging and spectroscopy device |
JP4241038B2 (en) * | 2000-10-30 | 2009-03-18 | ザ ジェネラル ホスピタル コーポレーション | Optical method and system for tissue analysis |
US9295391B1 (en) | 2000-11-10 | 2016-03-29 | The General Hospital Corporation | Spectrally encoded miniature endoscopic imaging probe |
DE10109539A1 (en) * | 2001-02-28 | 2002-09-12 | Siemens Ag | Device for examining tissue with light |
EP2333523B1 (en) * | 2001-04-30 | 2020-04-08 | The General Hospital Corporation | Method and apparatus for improving image clarity and sensitivity in optical coherence tomography using dynamic feedback to control focal properties and coherence gating |
US7865231B2 (en) | 2001-05-01 | 2011-01-04 | The General Hospital Corporation | Method and apparatus for determination of atherosclerotic plaque type by measurement of tissue optical properties |
US6980299B1 (en) * | 2001-10-16 | 2005-12-27 | General Hospital Corporation | Systems and methods for imaging a sample |
US7738032B2 (en) | 2001-11-08 | 2010-06-15 | Johnson & Johnson Consumer Companies, Inc. | Apparatus for and method of taking and viewing images of the skin |
US6907193B2 (en) | 2001-11-08 | 2005-06-14 | Johnson & Johnson Consumer Companies, Inc. | Method of taking polarized images of the skin and the use thereof |
US6922523B2 (en) | 2001-11-08 | 2005-07-26 | Johnson & Johnson Consumer Companies, Inc. | Method of promoting skin care products |
US7355716B2 (en) * | 2002-01-24 | 2008-04-08 | The General Hospital Corporation | Apparatus and method for ranging and noise reduction of low coherence interferometry LCI and optical coherence tomography OCT signals by parallel detection of spectral bands |
US20030147002A1 (en) * | 2002-02-06 | 2003-08-07 | Eastman Kodak Company | Method and apparatus for a color sequential scannerless range imaging system |
US8435791B2 (en) * | 2002-03-27 | 2013-05-07 | Hadasit Medical Research Services And Development Ltd. | Controlled laser treatment for non-invasive tissue alteration, treatment and diagnostics with minimal collateral damage |
US7725144B2 (en) * | 2002-04-04 | 2010-05-25 | Veralight, Inc. | Determination of disease state using raman spectroscopy of tissue |
US20110201924A1 (en) * | 2002-04-30 | 2011-08-18 | The General Hospital Corporation | Method and Apparatus for Improving Image Clarity and Sensitivity in Optical Tomography Using Dynamic Feedback to Control Focal Properties and Coherence Gating |
JP4499341B2 (en) * | 2002-05-09 | 2010-07-07 | ソニー株式会社 | Biometric authentication device and biometric authentication method |
US20050057797A1 (en) * | 2002-10-31 | 2005-03-17 | Treado Patrick J. | Apparatus and method for improved forensic detection |
US20040184660A1 (en) * | 2002-10-31 | 2004-09-23 | Treado Patrick J. | Method for improved forensic analysis |
US7408636B2 (en) * | 2002-10-31 | 2008-08-05 | Chemimage Corporation | Method and apparatus for dark field chemical imaging |
US7366333B2 (en) * | 2002-11-11 | 2008-04-29 | Art, Advanced Research Technologies, Inc. | Method and apparatus for selecting regions of interest in optical imaging |
AU2003302577A1 (en) * | 2002-12-02 | 2004-06-23 | Yeda Research And Development Co. Ltd. | Characterization of arteriosclerosis by optical imaging |
DE10257743B4 (en) * | 2002-12-10 | 2006-11-23 | Irmgard Zerrle | Device for determining perfusion in a tissue region and blood flow through individual blood vessels |
AU2003303361A1 (en) * | 2002-12-30 | 2004-07-22 | Koninklijke Philips Electronics N.V. | Analysis apparatus and method |
EP2319405B1 (en) * | 2003-01-24 | 2013-09-18 | The General Hospital Corporation | System and method for identifying tissue using low-coherence interferometry |
WO2004088361A2 (en) | 2003-03-31 | 2004-10-14 | The General Hospital Corporation | Speckle reduction in optical coherence tomography by path length encoded angular compounding |
US8054468B2 (en) | 2003-01-24 | 2011-11-08 | The General Hospital Corporation | Apparatus and method for ranging and noise reduction of low coherence interferometry LCI and optical coherence tomography OCT signals by parallel detection of spectral bands |
JP3770241B2 (en) * | 2003-03-04 | 2006-04-26 | 株式会社日立製作所 | Personal authentication device and personal authentication method |
US7991454B2 (en) | 2003-03-04 | 2011-08-02 | Academia Sinica | Imaging of biological structures |
JP2006520638A (en) * | 2003-03-18 | 2006-09-14 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | Analyzing components by monitoring |
US20040230098A1 (en) * | 2003-05-14 | 2004-11-18 | Inner Vision Imaging, L.L.C. | Endoscope illumination system |
KR101386971B1 (en) * | 2003-06-06 | 2014-04-18 | 더 제너럴 하스피탈 코포레이션 | Process and apparatus for a wavelength tunning source |
WO2005007215A2 (en) * | 2003-07-09 | 2005-01-27 | Glucolight Corporation | Method and apparatus for tissue oximetry |
US20060235308A1 (en) * | 2003-08-08 | 2006-10-19 | Van Beek Michael C | System for dark-field imaging of target areas below an object surface |
US7453564B2 (en) * | 2003-10-17 | 2008-11-18 | Koninklijke Philips Electronics N.V. | Method of determining a property of a fluid and spectroscopic system |
US7733497B2 (en) | 2003-10-27 | 2010-06-08 | The General Hospital Corporation | Method and apparatus for performing optical imaging using frequency-domain interferometry |
JP4556107B2 (en) * | 2003-10-30 | 2010-10-06 | ソニー株式会社 | Imaging apparatus and method, and communication terminal apparatus |
EP1687587B1 (en) * | 2003-11-28 | 2020-01-08 | The General Hospital Corporation | Method and apparatus for three-dimensional spectrally encoded imaging |
JP2005198788A (en) * | 2004-01-14 | 2005-07-28 | National Institute Of Information & Communication Technology | Biological activity measuring device |
US20050157939A1 (en) * | 2004-01-16 | 2005-07-21 | Mark Arsenault | Processes, products and systems for enhancing images of blood vessels |
US7510849B2 (en) * | 2004-01-29 | 2009-03-31 | Glucolight Corporation | OCT based method for diagnosis and therapy |
US20050168980A1 (en) * | 2004-01-30 | 2005-08-04 | Dryden Paul E. | Vein locator |
JP4793651B2 (en) * | 2004-02-20 | 2011-10-12 | 学校法人慶應義塾 | Sheath removal hole closing device using laser welding |
JP3905524B2 (en) * | 2004-03-16 | 2007-04-18 | 照男 武野 | Capillary blood flow observation device |
US20050215876A1 (en) * | 2004-03-25 | 2005-09-29 | Eastman Kodak Company | Method and system for automatic image adjustment for in vivo image diagnosis |
JP5054515B2 (en) * | 2004-04-26 | 2012-10-24 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | Electro-optic magnetic resonance transducer |
US20050257795A1 (en) * | 2004-05-20 | 2005-11-24 | Yu Hsiu-Chen | Method and apparatus for locating superficial veins or specific structures with a LED light source |
AU2004320269B2 (en) | 2004-05-29 | 2011-07-21 | The General Hospital Corporation | Process, system and software arrangement for a chromatic dispersion compensation using reflective layers in optical coherence tomography (OCT) imaging |
US7796243B2 (en) * | 2004-06-09 | 2010-09-14 | National Research Council Of Canada | Detection and monitoring of changes in mineralized tissues or calcified deposits by optical coherence tomography and Raman spectroscopy |
WO2006014392A1 (en) | 2004-07-02 | 2006-02-09 | The General Hospital Corporation | Endoscopic imaging probe comprising dual clad fibre |
US20060079750A1 (en) * | 2004-07-06 | 2006-04-13 | Fauci Mark A | Systems and methods for localizing vascular architecture, and evaluation and monitoring of functional behavior of same |
US20060020212A1 (en) * | 2004-07-26 | 2006-01-26 | Tianning Xu | Portable vein locating device |
US8081316B2 (en) * | 2004-08-06 | 2011-12-20 | The General Hospital Corporation | Process, system and software arrangement for determining at least one location in a sample using an optical coherence tomography |
WO2006020605A2 (en) * | 2004-08-10 | 2006-02-23 | The Regents Of The University Of California | Device and method for the delivery and/or elimination of compounds in tissue |
US7822452B2 (en) * | 2004-08-11 | 2010-10-26 | Glt Acquisition Corp. | Method for data reduction and calibration of an OCT-based blood glucose monitor |
US7254429B2 (en) | 2004-08-11 | 2007-08-07 | Glucolight Corporation | Method and apparatus for monitoring glucose levels in a biological tissue |
US8036727B2 (en) | 2004-08-11 | 2011-10-11 | Glt Acquisition Corp. | Methods for noninvasively measuring analyte levels in a subject |
US8208995B2 (en) | 2004-08-24 | 2012-06-26 | The General Hospital Corporation | Method and apparatus for imaging of vessel segments |
WO2006024014A2 (en) * | 2004-08-24 | 2006-03-02 | The General Hospital Corporation | Process, system and software arrangement for measuring a mechanical strain and elastic properties of a sample |
US7365859B2 (en) * | 2004-09-10 | 2008-04-29 | The General Hospital Corporation | System and method for optical coherence imaging |
CN101394783B (en) * | 2004-09-21 | 2014-03-19 | 数字信号公司 | System and method for remotely monitoring physiological functions |
EP2329759B1 (en) | 2004-09-29 | 2014-03-12 | The General Hospital Corporation | System and method for optical coherence imaging |
US8026942B2 (en) | 2004-10-29 | 2011-09-27 | Johnson & Johnson Consumer Companies, Inc. | Skin imaging system with probe |
JP5175101B2 (en) * | 2004-10-29 | 2013-04-03 | ザ ジェネラル ホスピタル コーポレイション | System and method for performing Jones matrix based analysis to measure unpolarized polarization parameters using polarization sensitive optical coherence tomography |
JP5623692B2 (en) * | 2004-11-02 | 2014-11-12 | ザ ジェネラル ホスピタル コーポレイション | Optical fiber rotator, optical system and method for sample imaging |
US7995210B2 (en) * | 2004-11-24 | 2011-08-09 | The General Hospital Corporation | Devices and arrangements for performing coherence range imaging using a common path interferometer |
JP2008521516A (en) | 2004-11-29 | 2008-06-26 | ザ ジェネラル ホスピタル コーポレイション | Configuration, apparatus, endoscope, catheter, and method for performing optical image generation by simultaneously illuminating and detecting multiple points on a sample |
US20060173351A1 (en) * | 2005-01-03 | 2006-08-03 | Ronald Marcotte | System and method for inserting a needle into a blood vessel |
US20060155194A1 (en) * | 2005-01-13 | 2006-07-13 | Ronald Marcotte | Method for detecting occlusions and leakages in subcutaneous blood vessels |
DE102005001682A1 (en) * | 2005-01-13 | 2006-08-10 | Siemens Ag | Apparatus for visualizing a lesion of a body part labeled with a fluorescent dye |
EP1860429A1 (en) * | 2005-02-10 | 2007-11-28 | Kanagawa Academy of Science and Technology | Circular dichroic thermal lens microscope |
EP2386245B1 (en) * | 2005-02-14 | 2012-12-19 | Digital Signal Corporation | Laser radar system for providing chirped electromagnetic radiation |
JP2008538612A (en) * | 2005-04-22 | 2008-10-30 | ザ ジェネラル ホスピタル コーポレイション | Configuration, system, and method capable of providing spectral domain polarization sensitive optical coherence tomography |
EP2325803A1 (en) | 2005-04-28 | 2011-05-25 | The General Hospital Corporation | Evaluating optical coherence tomography information for an anatomical structure |
EP1886121A1 (en) * | 2005-05-13 | 2008-02-13 | The General Hospital Corporation | Arrangements, systems and methods capable of providing spectral-domain optical coherence reflectometry for a sensitive detection of chemical and biological sample |
EP1887926B1 (en) * | 2005-05-31 | 2014-07-30 | The General Hospital Corporation | System and method which use spectral encoding heterodyne interferometry techniques for imaging |
US9060689B2 (en) | 2005-06-01 | 2015-06-23 | The General Hospital Corporation | Apparatus, method and system for performing phase-resolved optical frequency domain imaging |
ES2354287T3 (en) * | 2005-08-09 | 2011-03-11 | The General Hospital Corporation | APPARATUS AND METHOD FOR PERFORMING A DEMODULATION IN QUADRATURE BY POLARIZATION IN OPTICAL COHERENCE TOMOGRAPHY. |
US20070038118A1 (en) * | 2005-08-10 | 2007-02-15 | Depue Marshall Thomas | Subcutaneous tissue imager |
WO2007022220A2 (en) * | 2005-08-16 | 2007-02-22 | The General Hospital Corporation | Arrangements and methods for imaging in vessels |
US20070122344A1 (en) | 2005-09-02 | 2007-05-31 | University Of Rochester Medical Center Office Of Technology Transfer | Intraoperative determination of nerve location |
CN101365375B (en) | 2005-09-29 | 2013-09-11 | 通用医疗公司 | Method and apparatus for optical imaging via spectral encoding |
US7889348B2 (en) * | 2005-10-14 | 2011-02-15 | The General Hospital Corporation | Arrangements and methods for facilitating photoluminescence imaging |
CA2634033C (en) | 2005-12-14 | 2015-11-17 | Digital Signal Corporation | System and method for tracking eyeball motion |
EP1971848B1 (en) * | 2006-01-10 | 2019-12-04 | The General Hospital Corporation | Systems and methods for generating data based on one or more spectrally-encoded endoscopy techniques |
US20070223006A1 (en) * | 2006-01-19 | 2007-09-27 | The General Hospital Corporation | Systems and methods for performing rapid fluorescence lifetime, excitation and emission spectral measurements |
US8145018B2 (en) * | 2006-01-19 | 2012-03-27 | The General Hospital Corporation | Apparatus for obtaining information for a structure using spectrally-encoded endoscopy techniques and methods for producing one or more optical arrangements |
PL1973466T3 (en) | 2006-01-19 | 2021-07-05 | The General Hospital Corporation | Ballon imaging catheter |
US20070171433A1 (en) * | 2006-01-20 | 2007-07-26 | The General Hospital Corporation | Systems and processes for providing endogenous molecular imaging with mid-infrared light |
WO2007100935A2 (en) * | 2006-01-20 | 2007-09-07 | The General Hospital Corporation | Systems, arrangement and process for providing speckle reductions using a wave front modulation for optical coherence tomography |
WO2007084959A1 (en) * | 2006-01-20 | 2007-07-26 | The General Hospital Corporation | Systems and methods for providing mirror tunnel microscopy |
JP5524487B2 (en) * | 2006-02-01 | 2014-06-18 | ザ ジェネラル ホスピタル コーポレイション | A method and system for emitting electromagnetic radiation to at least a portion of a sample using a conformal laser treatment procedure. |
WO2007149603A2 (en) | 2006-02-01 | 2007-12-27 | The General Hospital Corporation | Apparatus for applying a plurality of electro-magnetic radiations to a sample |
WO2007149601A2 (en) * | 2006-02-01 | 2007-12-27 | The General Hospital Corporation | Apparatus for controlling at least one of at least two sections of at least one fiber |
JP5519152B2 (en) | 2006-02-08 | 2014-06-11 | ザ ジェネラル ホスピタル コーポレイション | Device for acquiring information about anatomical samples using optical microscopy |
US8081670B2 (en) | 2006-02-14 | 2011-12-20 | Digital Signal Corporation | System and method for providing chirped electromagnetic radiation |
EP1996910A2 (en) | 2006-02-22 | 2008-12-03 | Vivum Nexus LLC | Method and device for analyte measurement |
EP1987318B1 (en) * | 2006-02-24 | 2015-08-12 | The General Hospital Corporation | Methods and systems for performing angle-resolved fourier-domain optical coherence tomography |
WO2007103721A2 (en) * | 2006-03-01 | 2007-09-13 | The General Hospital Corporation | System and method for providing cell specific laser therapy of atherosclerotic plaques by targeting light absorbers in macrophages |
US20070270661A1 (en) * | 2006-03-28 | 2007-11-22 | Marc Philippon | Method and apparatus for monitoring blood flow to the hip joint |
JP5135324B2 (en) | 2006-04-05 | 2013-02-06 | ザ ジェネラル ホスピタル コーポレイション | Method, arrangement and system for polarization sensitive optical frequency domain imaging of samples |
JP4981888B2 (en) * | 2006-04-07 | 2012-07-25 | ノヴァリックス リミテッド | Vein navigation device |
EP2005877B1 (en) * | 2006-04-12 | 2014-01-08 | Olympus Medical Systems Corp. | Endoscope device |
US8442281B2 (en) * | 2006-04-28 | 2013-05-14 | The Invention Science Fund I, Llc | Artificially displaying information relative to a body |
EP2517616A3 (en) * | 2006-05-10 | 2013-03-06 | The General Hospital Corporation | Processes, arrangements and systems for providing frequency domain imaging of a sample |
WO2007133964A2 (en) * | 2006-05-12 | 2007-11-22 | The General Hospital Corporation | Processes, arrangements and systems for providing a fiber layer thickness map based on optical coherence tomography images |
EP2029020A4 (en) | 2006-06-22 | 2010-04-21 | Wisconsin Alumni Res Found | Stromal collagen in the diagnosis and characterization of breast cancer |
US20160296146A9 (en) * | 2006-06-29 | 2016-10-13 | Fred Wood | Apparatus-Mounted Vein Contrast Enchancer |
WO2008016927A2 (en) * | 2006-08-01 | 2008-02-07 | The General Hospital Corporation | Systems and methods for receiving and/or analyzing information associated with electro-magnetic radiation |
CN101589301B (en) * | 2006-08-25 | 2012-11-07 | 通用医疗公司 | Apparatus and methods for enhancing optical coherence tomography imaging using volumetric filtering techniques |
US20080161744A1 (en) | 2006-09-07 | 2008-07-03 | University Of Rochester Medical Center | Pre-And Intra-Operative Localization of Penile Sentinel Nodes |
US8270689B2 (en) * | 2006-09-12 | 2012-09-18 | Carestream Health, Inc. | Apparatus for caries detection |
US8214023B2 (en) * | 2006-09-21 | 2012-07-03 | Institute Of Critical Care Medicine | Microcirculation imaging |
WO2008049118A2 (en) * | 2006-10-19 | 2008-04-24 | The General Hospital Corporation | Apparatus and method for obtaining and providing imaging information associated with at least one portion of a sample and effecting such portion(s) |
EP2079363B1 (en) * | 2006-10-30 | 2020-06-10 | Elfi-Tech Ltd | Method for in vivo measurement of biological parameters |
US8498695B2 (en) | 2006-12-22 | 2013-07-30 | Novadaq Technologies Inc. | Imaging system with a single color image sensor for simultaneous fluorescence and color video endoscopy |
US20080206804A1 (en) * | 2007-01-19 | 2008-08-28 | The General Hospital Corporation | Arrangements and methods for multidimensional multiplexed luminescence imaging and diagnosis |
US7911621B2 (en) | 2007-01-19 | 2011-03-22 | The General Hospital Corporation | Apparatus and method for controlling ranging depth in optical frequency domain imaging |
US7949019B2 (en) * | 2007-01-19 | 2011-05-24 | The General Hospital | Wavelength tuning source based on a rotatable reflector |
WO2008109414A2 (en) * | 2007-03-02 | 2008-09-12 | Wisconsin Alumni Research Foundation | Use of endogenous fluorescence to identify invading metastatic breast tumor cells |
WO2008116010A1 (en) * | 2007-03-19 | 2008-09-25 | The General Hospital Corporation | System and method for providing noninvasive diagnosis of compartment syndrome exemplary laser speckle imaging procedure |
WO2008115965A1 (en) * | 2007-03-19 | 2008-09-25 | The General Hospital Corporation | Apparatus and method for providing a noninvasive diagnosis of internal bleeding |
US20090018414A1 (en) * | 2007-03-23 | 2009-01-15 | Mehrdad Toofan | Subcutanous Blood Vessels Imaging System |
EP2602651A3 (en) * | 2007-03-23 | 2014-08-27 | The General Hospital Corporation | Methods, arrangements and apparatus for utilizing a wavelength-swept laser using angular scanning and dispersion procedures |
US10534129B2 (en) * | 2007-03-30 | 2020-01-14 | The General Hospital Corporation | System and method providing intracoronary laser speckle imaging for the detection of vulnerable plaque |
JP4407714B2 (en) * | 2007-04-06 | 2010-02-03 | セイコーエプソン株式会社 | Biometric authentication device and biometric authentication method |
WO2008131082A1 (en) | 2007-04-17 | 2008-10-30 | The General Hospital Corporation | Apparatus and methods for measuring vibrations using spectrally-encoded endoscopy techniques |
US8115919B2 (en) * | 2007-05-04 | 2012-02-14 | The General Hospital Corporation | Methods, arrangements and systems for obtaining information associated with a sample using optical microscopy |
US8068899B2 (en) * | 2007-07-03 | 2011-11-29 | The Board Of Trustees Of The Leland Stanford Junior University | Method and system of using intrinsic-based photosensing with high-speed line scanning for characterization of biological thick tissue including muscle |
JP5917803B2 (en) * | 2007-07-31 | 2016-05-18 | ザ ジェネラル ホスピタル コーポレイション | System and method for emitting a beam scanning pattern for fast Doppler optical frequency domain imaging |
EP2191254B1 (en) * | 2007-08-31 | 2017-07-19 | The General Hospital Corporation | System and method for self-interference fluorescence microscopy, and computer-accessible medium associated therewith |
US20090073439A1 (en) * | 2007-09-15 | 2009-03-19 | The General Hospital Corporation | Apparatus, computer-accessible medium and method for measuring chemical and/or molecular compositions of coronary atherosclerotic plaques in anatomical structures |
US20090076396A1 (en) * | 2007-09-17 | 2009-03-19 | The General Hospital Corporation | Optical wavelength range for high contrast imaging of cancer |
EP2040061A1 (en) * | 2007-09-24 | 2009-03-25 | Koninklijke Philips Electronics N.V. | An apparatus and method for observing the surface of a sample |
CN101809431B (en) * | 2007-09-24 | 2014-03-26 | 皇家飞利浦电子股份有限公司 | An apparatus for observing the surface of a sample |
US20090131801A1 (en) * | 2007-10-12 | 2009-05-21 | The General Hospital Corporation | Systems and processes for optical imaging of luminal anatomic structures |
WO2009059034A1 (en) * | 2007-10-30 | 2009-05-07 | The General Hospital Corporation | System and method for cladding mode detection |
EP2207474B1 (en) * | 2007-11-05 | 2018-08-22 | Biosensor, Inc. | Optical sensor for determining the concentration of an analyte |
JP5376206B2 (en) * | 2007-12-05 | 2013-12-25 | 富士フイルム株式会社 | Location system and program |
US8811763B2 (en) * | 2007-12-06 | 2014-08-19 | The United States Of America As Represented By The Secretary Of The Army | Method and system for producing image frames using quantum properties |
US20090225324A1 (en) * | 2008-01-17 | 2009-09-10 | The General Hospital Corporation | Apparatus for providing endoscopic high-speed optical coherence tomography |
US8406860B2 (en) | 2008-01-25 | 2013-03-26 | Novadaq Technologies Inc. | Method for evaluating blush in myocardial tissue |
US9332942B2 (en) * | 2008-01-28 | 2016-05-10 | The General Hospital Corporation | Systems, processes and computer-accessible medium for providing hybrid flourescence and optical coherence tomography imaging |
US11123047B2 (en) | 2008-01-28 | 2021-09-21 | The General Hospital Corporation | Hybrid systems and methods for multi-modal acquisition of intravascular imaging data and counteracting the effects of signal absorption in blood |
DE102008008559A1 (en) * | 2008-02-08 | 2009-08-13 | Robert Bosch Gmbh | interferometer |
WO2009111542A2 (en) | 2008-03-04 | 2009-09-11 | Glucolight Corporation | Methods and systems for analyte level estimation in optical coherence tomography |
JP5231625B2 (en) * | 2008-03-18 | 2013-07-10 | ノヴァダク テクノロジーズ インコーポレイテッド | Imaging system for acquiring NIR and full color images and method of operation thereof |
US7792334B2 (en) * | 2008-03-31 | 2010-09-07 | Immersion Corporation | Locating blood vessels |
US8467857B2 (en) * | 2008-04-11 | 2013-06-18 | Seoul National University R & Db Foundation | Hypodermic vein detection imaging apparatus based on infrared optical system |
US8611975B2 (en) * | 2009-10-28 | 2013-12-17 | Gluco Vista, Inc. | Apparatus and method for non-invasive measurement of a substance within a body |
US10219742B2 (en) | 2008-04-14 | 2019-03-05 | Novadaq Technologies ULC | Locating and analyzing perforator flaps for plastic and reconstructive surgery |
US8838211B2 (en) * | 2008-04-30 | 2014-09-16 | Board Of Regents, The University Of Texas System | Multi-wavelength diagnostic imager |
EP2285272A4 (en) * | 2008-04-30 | 2017-01-04 | Board of Regents, The University of Texas System | Integrated patient bed system |
EP3372250B1 (en) | 2008-05-02 | 2019-12-25 | Novadaq Technologies ULC | Methods for production and use of substance-loaded erythrocytes for observation and treatment of microvascular hemodynamics |
EP2274572A4 (en) | 2008-05-07 | 2013-08-28 | Gen Hospital Corp | System, method and computer-accessible medium for tracking vessel motion during three-dimensional coronary artery microscopy |
WO2009155536A2 (en) | 2008-06-20 | 2009-12-23 | The General Hospital Corporation | Fused fiber optic coupler arrangement and method for use thereof |
WO2010009136A2 (en) | 2008-07-14 | 2010-01-21 | The General Hospital Corporation | Apparatus and methods for color endoscopy |
US8620409B2 (en) | 2008-08-04 | 2013-12-31 | University Of Utah Research Foundation | Dye application for confocal imaging of cellular microstructure |
EP2186467A1 (en) * | 2008-11-18 | 2010-05-19 | UMC Utrecht Holding B.V. | Apparatus and method for determining the position of a vein or artery. |
JP5731394B2 (en) | 2008-12-10 | 2015-06-10 | ザ ジェネラル ホスピタル コーポレイション | System, apparatus and method for extending imaging depth range of optical coherence tomography through optical subsampling |
US8503712B2 (en) * | 2008-12-31 | 2013-08-06 | Motorola Mobility Llc | Method and apparatus for determining blood oxygenation using a mobile communication device |
US9615748B2 (en) | 2009-01-20 | 2017-04-11 | The General Hospital Corporation | Endoscopic biopsy apparatus, system and method |
WO2010085775A2 (en) * | 2009-01-26 | 2010-07-29 | The General Hospital Corporation | System, method and computer-accessible medium for providing wide-field superresolution microscopy |
CN102308444B (en) | 2009-02-04 | 2014-06-18 | 通用医疗公司 | Apparatus and method for utilization of a high-speed optical wavelength tuning source |
WO2010096453A1 (en) | 2009-02-17 | 2010-08-26 | Board Of Regents, The University Of Texas System | Methods of producing laser speckle contrast images |
EP2399150B1 (en) | 2009-02-20 | 2020-10-07 | StereoVision Imaging, Inc. | System and method for generating three dimensional images using lidar and video measurements |
US9351642B2 (en) | 2009-03-12 | 2016-05-31 | The General Hospital Corporation | Non-contact optical system, computer-accessible medium and method for measurement at least one mechanical property of tissue using coherent speckle technique(s) |
US10492671B2 (en) | 2009-05-08 | 2019-12-03 | Novadaq Technologies ULC | Near infra red fluorescence imaging for visualization of blood vessels during endoscopic harvest |
JP5667173B2 (en) * | 2009-05-18 | 2015-02-12 | コーニンクレッカ フィリップス エヌ ヴェ | Apparatus for influencing and detecting magnetic particles and method of operating the same |
US8498694B2 (en) * | 2009-07-13 | 2013-07-30 | Entrotech, Inc. | Subcutaneous access device and related methods |
BR112012001042A2 (en) | 2009-07-14 | 2016-11-22 | Gen Hospital Corp | fluid flow measurement equipment and method within anatomical structure. |
US20110082355A1 (en) * | 2009-07-30 | 2011-04-07 | Oxitone Medical Ltd. | Photoplethysmography device and method |
US8983567B1 (en) | 2009-08-01 | 2015-03-17 | Nuvasive, Inc. | Systems and methods for vessel avoidance during spine surgery |
US8723118B2 (en) * | 2009-10-01 | 2014-05-13 | Microsoft Corporation | Imager for constructing color and depth images |
US20110137178A1 (en) * | 2009-10-06 | 2011-06-09 | The General Hospital Corporation | Devices and methods for imaging particular cells including eosinophils |
US8903466B2 (en) | 2009-10-28 | 2014-12-02 | Glucovista Inc. | Apparatus and method for non-invasive measurement of a substance within a body |
JP5658873B2 (en) * | 2009-11-13 | 2015-01-28 | オリンパス株式会社 | Image processing apparatus, electronic apparatus, endoscope system, and program |
US20130016185A1 (en) * | 2009-11-19 | 2013-01-17 | The John Hopkins University | Low-cost image-guided navigation and intervention systems using cooperative sets of local sensors |
WO2011072055A2 (en) * | 2009-12-08 | 2011-06-16 | The General Hospital Corporation | Methods and arrangements for analysis, diagnosis, and treatment monitoring of vocal folds by optical coherence tomography |
US8514284B2 (en) | 2009-12-17 | 2013-08-20 | Raytheon Company | Textured pattern sensing and detection, and using a charge-scavenging photodiode array for the same |
JP5297997B2 (en) * | 2009-12-21 | 2013-09-25 | 株式会社日立メディアエレクトロニクス | Personal authentication device and mobile communication terminal |
ES2831223T3 (en) | 2010-03-05 | 2021-06-07 | Massachusetts Gen Hospital | Apparatus for providing electromagnetic radiation to a sample |
WO2011116347A1 (en) | 2010-03-19 | 2011-09-22 | Quickvein, Inc. | Apparatus and methods for imaging blood vessels |
US9066658B2 (en) * | 2010-03-23 | 2015-06-30 | Stryker Corporation | Method and system for video based image detection/identification analysis for fluid and visualization control |
US8660324B2 (en) * | 2010-03-29 | 2014-02-25 | Raytheon Company | Textured pattern sensing using partial-coherence speckle interferometry |
US8780182B2 (en) * | 2010-03-31 | 2014-07-15 | Raytheon Company | Imaging system and method using partial-coherence speckle interference tomography |
US9069130B2 (en) | 2010-05-03 | 2015-06-30 | The General Hospital Corporation | Apparatus, method and system for generating optical radiation from biological gain media |
US9795301B2 (en) | 2010-05-25 | 2017-10-24 | The General Hospital Corporation | Apparatus, systems, methods and computer-accessible medium for spectral analysis of optical coherence tomography images |
US9557154B2 (en) | 2010-05-25 | 2017-01-31 | The General Hospital Corporation | Systems, devices, methods, apparatus and computer-accessible media for providing optical imaging of structures and compositions |
EP2575591A4 (en) | 2010-06-03 | 2017-09-13 | The General Hospital Corporation | Apparatus and method for devices for imaging structures in or at one or more luminal organs |
EP2420179B1 (en) * | 2010-08-16 | 2020-10-07 | Cognoptix, Inc. | System and method for detecting amyloid proteins |
JP5445407B2 (en) * | 2010-09-08 | 2014-03-19 | 横河電機株式会社 | Biological information measuring device |
US8996086B2 (en) * | 2010-09-17 | 2015-03-31 | OptimumTechnologies, Inc. | Digital mapping system and method |
US9510758B2 (en) | 2010-10-27 | 2016-12-06 | The General Hospital Corporation | Apparatus, systems and methods for measuring blood pressure within at least one vessel |
WO2012075126A2 (en) * | 2010-11-30 | 2012-06-07 | The Board Of Regents Of The University Of Texas System | Methods and apparatus related to photothermal optical coherence tomography (oct) |
JP5657375B2 (en) * | 2010-12-24 | 2015-01-21 | オリンパス株式会社 | Endoscope apparatus and program |
EP2667778B1 (en) | 2011-01-28 | 2021-04-28 | Bar Ilan University | Method and system for non-invasively monitoring biological or biochemical parameters of individual |
US9636041B2 (en) | 2011-01-28 | 2017-05-02 | Bar Ilan University | Method and system for non-invasively monitoring biological or biochemical parameters of individual |
CN103765091B (en) | 2011-03-08 | 2017-09-26 | 诺瓦达克技术公司 | Full spectrum LED illuminator |
WO2012149175A1 (en) | 2011-04-29 | 2012-11-01 | The General Hospital Corporation | Means for determining depth-resolved physical and/or optical properties of scattering media |
WO2013013049A1 (en) | 2011-07-19 | 2013-01-24 | The General Hospital Corporation | Systems, methods, apparatus and computer-accessible-medium for providing polarization-mode dispersion compensation in optical coherence tomography |
JP5450527B2 (en) * | 2011-08-10 | 2014-03-26 | 富士フイルム株式会社 | Endoscope device |
WO2013024478A1 (en) * | 2011-08-14 | 2013-02-21 | Uzi Rahum | Blood vessel recognition and printing system using diffuse light |
US10241028B2 (en) | 2011-08-25 | 2019-03-26 | The General Hospital Corporation | Methods, systems, arrangements and computer-accessible medium for providing micro-optical coherence tomography procedures |
EP2769491A4 (en) | 2011-10-18 | 2015-07-22 | Gen Hospital Corp | Apparatus and methods for producing and/or providing recirculating optical delay(s) |
JP2013122443A (en) * | 2011-11-11 | 2013-06-20 | Hideo Ando | Biological activity measuring method, biological activity measuring device, method for transfer of biological activity detection signal and method for provision of service using biological activity information |
WO2013090658A1 (en) | 2011-12-14 | 2013-06-20 | The Trustees Of The University Of Pennsylvania | Fiber optic flow and oxygenation monitoring using diffuse correlation and reflectance |
WO2013148306A1 (en) | 2012-03-30 | 2013-10-03 | The General Hospital Corporation | Imaging system, method and distal attachment for multidirectional field of view endoscopy |
WO2013156908A1 (en) * | 2012-04-17 | 2013-10-24 | Koninklijke Philips N.V. | Device and method for obtaining vital sign information of a living being |
WO2013177154A1 (en) | 2012-05-21 | 2013-11-28 | The General Hospital Corporation | Apparatus, device and method for capsule microscopy |
CA2914778A1 (en) | 2012-06-21 | 2013-12-27 | Novadaq Technologies Inc. | Quantification and analysis of angiography and perfusion |
DE102012012695A1 (en) * | 2012-06-27 | 2014-01-02 | Otto Bock Healthcare Gmbh | Apparatus and method for determining relative displacements of body parts or body parts |
CN104736042B (en) | 2012-08-01 | 2017-09-12 | 巴伊兰大学 | Biological parameter or the method and system of biochemical parameter for non-invasively monitoring individual |
JP6227652B2 (en) | 2012-08-22 | 2017-11-08 | ザ ジェネラル ホスピタル コーポレイション | System, method, and computer-accessible medium for fabricating a miniature endoscope using soft lithography |
US20140100550A1 (en) * | 2012-10-10 | 2014-04-10 | Christie Digital Systems Canada Inc. | Catheter discrimination and guidance system |
US20140100524A1 (en) * | 2012-10-10 | 2014-04-10 | Christie Digital Systems Usa, Inc. | Catheter discrimination and guidance system |
US9412155B2 (en) | 2012-12-31 | 2016-08-09 | Karl Storz Imaging, Inc. | Video system with dynamic contrast and detail enhancement |
JP6560126B2 (en) | 2013-01-28 | 2019-08-14 | ザ ジェネラル ホスピタル コーポレイション | Apparatus and method for providing diffusion spectroscopy superimposed on optical frequency domain imaging |
WO2014120791A1 (en) | 2013-01-29 | 2014-08-07 | The General Hospital Corporation | Apparatus, systems and methods for providing information regarding the aortic valve |
US11179028B2 (en) | 2013-02-01 | 2021-11-23 | The General Hospital Corporation | Objective lens arrangement for confocal endomicroscopy |
WO2014168734A1 (en) | 2013-03-15 | 2014-10-16 | Cedars-Sinai Medical Center | Time-resolved laser-induced fluorescence spectroscopy systems and uses thereof |
JP6378311B2 (en) | 2013-03-15 | 2018-08-22 | ザ ジェネラル ホスピタル コーポレイション | Methods and systems for characterizing objects |
US20140276088A1 (en) * | 2013-03-15 | 2014-09-18 | Steven H. Drucker | Illumination Optics for a Visible or Infrared Based Apparatus and Methods for Viewing or Imaging Blood Vessels |
JP2014239871A (en) | 2013-05-07 | 2014-12-25 | 安東 秀夫 | Biological activity detection method, biological activity measuring apparatus, biological activity detection signal transfer method, and providing method of service using biological activity information |
WO2014186353A1 (en) | 2013-05-13 | 2014-11-20 | The General Hospital Corporation | Detecting self-interefering fluorescence phase and amplitude |
US20160124250A1 (en) * | 2013-05-23 | 2016-05-05 | President And Fellows Of Harvard College | Pixelated tunable color filter |
EP3003177B1 (en) | 2013-05-31 | 2021-03-10 | Covidien LP | Surgical device with an end-effector assembly for monitoring of tissue during a surgical procedure |
US10939869B2 (en) | 2013-06-18 | 2021-03-09 | Lawrence Livermore National Security, Llc | Imaging system and method for enhanced visualization of near surface vascular structures |
EP2815695B1 (en) * | 2013-06-20 | 2019-06-19 | Erbe Elektromedizin GmbH | Surgical instrument with tissue detection |
EP3021735A4 (en) | 2013-07-19 | 2017-04-19 | The General Hospital Corporation | Determining eye motion by imaging retina. with feedback |
WO2015009932A1 (en) | 2013-07-19 | 2015-01-22 | The General Hospital Corporation | Imaging apparatus and method which utilizes multidirectional field of view endoscopy |
EP3025173B1 (en) | 2013-07-26 | 2021-07-07 | The General Hospital Corporation | Apparatus with a laser arrangement utilizing optical dispersion for applications in fourier-domain optical coherence tomography |
CN104414620B (en) * | 2013-08-23 | 2017-07-07 | 东莞市中健医疗设备科技有限公司 | Vein localization method and device based on binocular camera shooting |
JP5869541B2 (en) * | 2013-09-13 | 2016-02-24 | 富士フイルム株式会社 | ENDOSCOPE SYSTEM, PROCESSOR DEVICE, AND METHOD FOR OPERATING ENDOSCOPE SYSTEM |
US9622720B2 (en) | 2013-11-27 | 2017-04-18 | Clear Guide Medical, Inc. | Ultrasound system with stereo image guidance or tracking |
US8880151B1 (en) | 2013-11-27 | 2014-11-04 | Clear Guide Medical, Llc | Surgical needle for a surgical system with optical recognition |
US9733460B2 (en) | 2014-01-08 | 2017-08-15 | The General Hospital Corporation | Method and apparatus for microscopic imaging |
WO2015116986A2 (en) | 2014-01-31 | 2015-08-06 | The General Hospital Corporation | System and method for facilitating manual and/or automatic volumetric imaging with real-time tension or force feedback using a tethered imaging device |
WO2015153982A1 (en) | 2014-04-04 | 2015-10-08 | The General Hospital Corporation | Apparatus and method for controlling propagation and/or transmission of electromagnetic radiation in flexible waveguide(s) |
EP3145397A4 (en) * | 2014-05-23 | 2018-01-17 | Covidien LP | Systems for imaging of blood flow in laparoscopy |
US10599932B2 (en) | 2014-06-09 | 2020-03-24 | Lawrence Livermore National Security, Llc | Personal electronic device for performing multimodal imaging for non-contact identification of multiple biometric traits |
US9659205B2 (en) | 2014-06-09 | 2017-05-23 | Lawrence Livermore National Security, Llc | Multimodal imaging system and method for non-contact identification of multiple biometric traits |
WO2016003268A2 (en) * | 2014-06-30 | 2016-01-07 | Scint B.V. | Method and device for measuring a health status and physiological parameters of an user at rest and under movement |
WO2016015052A1 (en) | 2014-07-25 | 2016-01-28 | The General Hospital Corporation | Apparatus, devices and methods for in vivo imaging and diagnosis |
WO2016040791A2 (en) * | 2014-09-12 | 2016-03-17 | Research Development Foundation | Systems and methods for imaging and manipulating tissue |
EP3201607B1 (en) | 2014-09-29 | 2020-12-30 | Novadaq Technologies ULC | Imaging a target fluorophore in a biological material in the presence of autofluorescence |
CA2963450A1 (en) | 2014-10-09 | 2016-04-14 | Novadaq Technologies Inc. | Quantification of absolute blood flow in tissue using fluorescence-mediated photoplethysmography |
WO2016061052A1 (en) | 2014-10-14 | 2016-04-21 | East Carolina University | Methods, systems and computer program products for visualizing anatomical structures and blood flow and perfusion physiology using imaging techniques |
US11553844B2 (en) | 2014-10-14 | 2023-01-17 | East Carolina University | Methods, systems and computer program products for calculating MetaKG signals for regions having multiple sets of optical characteristics |
CA2963866C (en) | 2014-10-14 | 2023-11-07 | East Carolina University | Methods, systems and computer program products for determining hemodynamic status parameters using signals derived from multispectral blood flow and perfusion imaging |
US11304604B2 (en) | 2014-10-29 | 2022-04-19 | Spectral Md, Inc. | Reflective mode multi-spectral time-resolved optical imaging methods and apparatuses for tissue classification |
US9717417B2 (en) | 2014-10-29 | 2017-08-01 | Spectral Md, Inc. | Reflective mode multi-spectral time-resolved optical imaging methods and apparatuses for tissue classification |
CN104305955B (en) * | 2014-11-06 | 2016-03-09 | 佛山市南海区欧谱曼迪科技有限责任公司 | Wide field optical coherence tomography electronic colposcope imaging system |
US10779713B2 (en) * | 2014-12-09 | 2020-09-22 | Chemimage Corporation | Molecular chemical imaging endoscopic imaging systems |
US9931040B2 (en) * | 2015-01-14 | 2018-04-03 | Verily Life Sciences Llc | Applications of hyperspectral laser speckle imaging |
US10058256B2 (en) * | 2015-03-20 | 2018-08-28 | East Carolina University | Multi-spectral laser imaging (MSLI) methods and systems for blood flow and perfusion imaging and quantification |
US10390718B2 (en) | 2015-03-20 | 2019-08-27 | East Carolina University | Multi-spectral physiologic visualization (MSPV) using laser imaging methods and systems for blood flow and perfusion imaging and quantification in an endoscopic design |
DE102015006406A1 (en) | 2015-05-19 | 2016-12-08 | SAMTD GmbH & Co. KG | Method and device for the non-invasive determination of a measurand of an analyte in a biological body |
IL239113A (en) | 2015-06-01 | 2016-12-29 | Elbit Systems Land & C4I Ltd | System and method for determining audio characteristics from within a body |
CN113648067A (en) | 2015-11-13 | 2021-11-16 | 史赛克欧洲运营有限公司 | System and method for illumination and imaging of an object |
CN105380638B (en) * | 2015-12-15 | 2019-02-26 | 黄恺 | A kind of quantitative imaging devices and methods therefor for laser speckle blood flow velocity |
WO2017127929A1 (en) | 2016-01-26 | 2017-08-03 | Novadaq Technologies Inc. | Configurable platform |
US10412280B2 (en) | 2016-02-10 | 2019-09-10 | Microsoft Technology Licensing, Llc | Camera with light valve over sensor array |
JP7245051B2 (en) | 2016-03-08 | 2023-03-23 | エンスペクトラ・ヘルス・インコーポレイテッド | Non-invasive detection of skin diseases |
WO2017173315A1 (en) * | 2016-04-01 | 2017-10-05 | Black Light Surgical, Inc. | Systems, devices, and methods for time-resolved fluorescent spectroscopy |
US20170303848A1 (en) * | 2016-04-26 | 2017-10-26 | The Board Of Regents Of The University Of Texas System | Infravein Vasculature Visualization Device |
USD916294S1 (en) | 2016-04-28 | 2021-04-13 | Stryker European Operations Limited | Illumination and imaging device |
CA3027592A1 (en) | 2016-06-14 | 2017-12-21 | John Josef Paul FENGLER | Methods and systems for adaptive imaging for low light signal enhancement in medical visualization |
CN106264453B (en) * | 2016-07-25 | 2018-10-16 | 深圳先进技术研究院 | Endoscopic imaging and laser speckle imaging fusion imaging system |
CN106073801A (en) * | 2016-08-16 | 2016-11-09 | 深圳信息职业技术学院 | A kind of external cavum nasopharyngeum vena systemica blood oxygen saturation formation method and device |
JP6392486B1 (en) * | 2017-02-01 | 2018-09-19 | オリンパス株式会社 | Endoscope system |
CA3049922A1 (en) | 2017-02-10 | 2018-08-16 | Novadaq Technologies ULC | Open-field handheld fluorescence imaging systems and methods |
US20220240783A1 (en) | 2017-03-02 | 2022-08-04 | Spectral Md, Inc. | Machine learning systems and techniques for multispectral amputation site analysis |
US20180292262A1 (en) * | 2017-04-06 | 2018-10-11 | The Government Of The United States Of America, As Represented By The Secretary Of The Navy | Laser speckle reduction and photo-thermal speckle spectroscopy |
WO2018201082A1 (en) | 2017-04-28 | 2018-11-01 | Zebra Medical Technologies, Inc. | Systems and methods for imaging and measurement of sarcomeres |
EP3731726A4 (en) | 2017-12-27 | 2021-10-27 | Ethicon LLC | Hyperspectral imaging in a light deficient environment |
US10775149B1 (en) * | 2018-03-14 | 2020-09-15 | Onto Innovation Inc. | Light source failure identification in an optical metrology device |
CN108498079B (en) * | 2018-05-08 | 2021-04-27 | 大美医喆(北京)医疗科技有限公司 | Method and equipment for identifying blood vessels, lymphatic vessels and lymph nodes in fluorescence-polluted environment |
US10928617B1 (en) | 2018-05-18 | 2021-02-23 | GDH Enterprises, LLC | Portable three-dimensional virtual imaging device |
EP3814754A4 (en) * | 2018-06-28 | 2022-05-04 | Children's National Medical Center | Methods and system for dye-free visualization of blood flow and tissue perfusion in laparoscopy |
US10783632B2 (en) | 2018-12-14 | 2020-09-22 | Spectral Md, Inc. | Machine learning systems and method for assessment, healing prediction, and treatment of wounds |
CN113260303A (en) | 2018-12-14 | 2021-08-13 | 光谱Md公司 | Machine learning systems and methods for assessing, healing predicting, and treating wounds |
JP7186298B2 (en) | 2018-12-14 | 2022-12-08 | スペクトラル エムディー,インコーポレイテッド | Systems and methods for high-precision multi-aperture spectral imaging |
US10740884B2 (en) | 2018-12-14 | 2020-08-11 | Spectral Md, Inc. | System and method for high precision multi-aperture spectral imaging |
AU2020209518A1 (en) * | 2019-01-17 | 2021-08-26 | Sbi Alapharma Canada, Inc. | Modular endoscopic system for visualization of disease |
USD908881S1 (en) | 2019-01-17 | 2021-01-26 | Sbi Alapharma Canada, Inc. | Handheld endoscopic imaging device |
JP6999597B2 (en) * | 2019-03-27 | 2022-01-18 | 富士フイルム株式会社 | Processor device and its operation method and endoscopic system |
JP7211497B2 (en) * | 2019-05-16 | 2023-01-24 | 日本電気株式会社 | Optical coherence tomographic imaging apparatus, imaging method, and imaging program |
US11432706B2 (en) | 2019-06-20 | 2022-09-06 | Cilag Gmbh International | Hyperspectral imaging with minimal area monolithic image sensor |
US11931009B2 (en) | 2019-06-20 | 2024-03-19 | Cilag Gmbh International | Offset illumination of a scene using multiple emitters in a hyperspectral imaging system |
US11076747B2 (en) | 2019-06-20 | 2021-08-03 | Cilag Gmbh International | Driving light emissions according to a jitter specification in a laser mapping imaging system |
US11671691B2 (en) | 2019-06-20 | 2023-06-06 | Cilag Gmbh International | Image rotation in an endoscopic laser mapping imaging system |
US11758256B2 (en) | 2019-06-20 | 2023-09-12 | Cilag Gmbh International | Fluorescence imaging in a light deficient environment |
US11147436B2 (en) | 2019-06-20 | 2021-10-19 | Cilag Gmbh International | Image rotation in an endoscopic fluorescence imaging system |
US11291358B2 (en) | 2019-06-20 | 2022-04-05 | Cilag Gmbh International | Fluorescence videostroboscopy of vocal cords |
US11412920B2 (en) | 2019-06-20 | 2022-08-16 | Cilag Gmbh International | Speckle removal in a pulsed fluorescence imaging system |
US11471055B2 (en) | 2019-06-20 | 2022-10-18 | Cilag Gmbh International | Noise aware edge enhancement in a pulsed fluorescence imaging system |
US11937784B2 (en) | 2019-06-20 | 2024-03-26 | Cilag Gmbh International | Fluorescence imaging in a light deficient environment |
US11540696B2 (en) | 2019-06-20 | 2023-01-03 | Cilag Gmbh International | Noise aware edge enhancement in a pulsed fluorescence imaging system |
US10841504B1 (en) | 2019-06-20 | 2020-11-17 | Ethicon Llc | Fluorescence imaging with minimal area monolithic image sensor |
US11716543B2 (en) | 2019-06-20 | 2023-08-01 | Cilag Gmbh International | Wide dynamic range using a monochrome image sensor for fluorescence imaging |
US11516388B2 (en) | 2019-06-20 | 2022-11-29 | Cilag Gmbh International | Pulsed illumination in a fluorescence imaging system |
US11624830B2 (en) | 2019-06-20 | 2023-04-11 | Cilag Gmbh International | Wide dynamic range using a monochrome image sensor for laser mapping imaging |
US11925328B2 (en) | 2019-06-20 | 2024-03-12 | Cilag Gmbh International | Noise aware edge enhancement in a pulsed hyperspectral imaging system |
US20200397246A1 (en) | 2019-06-20 | 2020-12-24 | Ethicon Llc | Minimizing image sensor input/output in a pulsed hyperspectral, fluorescence, and laser mapping imaging system |
US11700995B2 (en) | 2019-06-20 | 2023-07-18 | Cilag Gmbh International | Speckle removal in a pulsed fluorescence imaging system |
US11237270B2 (en) | 2019-06-20 | 2022-02-01 | Cilag Gmbh International | Hyperspectral, fluorescence, and laser mapping imaging with fixed pattern noise cancellation |
US11398011B2 (en) | 2019-06-20 | 2022-07-26 | Cilag Gmbh International | Super resolution and color motion artifact correction in a pulsed laser mapping imaging system |
US11360028B2 (en) | 2019-06-20 | 2022-06-14 | Cilag Gmbh International | Super resolution and color motion artifact correction in a pulsed hyperspectral, fluorescence, and laser mapping imaging system |
US11284785B2 (en) | 2019-06-20 | 2022-03-29 | Cilag Gmbh International | Controlling integral energy of a laser pulse in a hyperspectral, fluorescence, and laser mapping imaging system |
US11898909B2 (en) | 2019-06-20 | 2024-02-13 | Cilag Gmbh International | Noise aware edge enhancement in a pulsed fluorescence imaging system |
US11533417B2 (en) | 2019-06-20 | 2022-12-20 | Cilag Gmbh International | Laser scanning and tool tracking imaging in a light deficient environment |
US11187658B2 (en) | 2019-06-20 | 2021-11-30 | Cilag Gmbh International | Fluorescence imaging with fixed pattern noise cancellation |
US11389066B2 (en) | 2019-06-20 | 2022-07-19 | Cilag Gmbh International | Noise aware edge enhancement in a pulsed hyperspectral, fluorescence, and laser mapping imaging system |
US20200397239A1 (en) | 2019-06-20 | 2020-12-24 | Ethicon Llc | Offset illumination of a scene using multiple emitters in a fluorescence imaging system |
US11633089B2 (en) | 2019-06-20 | 2023-04-25 | Cilag Gmbh International | Fluorescence imaging with minimal area monolithic image sensor |
US11793399B2 (en) | 2019-06-20 | 2023-10-24 | Cilag Gmbh International | Super resolution and color motion artifact correction in a pulsed hyperspectral imaging system |
US11550057B2 (en) | 2019-06-20 | 2023-01-10 | Cilag Gmbh International | Offset illumination of a scene using multiple emitters in a fluorescence imaging system |
US11412152B2 (en) | 2019-06-20 | 2022-08-09 | Cilag Gmbh International | Speckle removal in a pulsed hyperspectral imaging system |
US11622094B2 (en) | 2019-06-20 | 2023-04-04 | Cilag Gmbh International | Wide dynamic range using a monochrome image sensor for fluorescence imaging |
US11213194B2 (en) | 2019-06-20 | 2022-01-04 | Cilag Gmbh International | Optical fiber waveguide in an endoscopic system for hyperspectral, fluorescence, and laser mapping imaging |
US11674848B2 (en) | 2019-06-20 | 2023-06-13 | Cilag Gmbh International | Wide dynamic range using a monochrome image sensor for hyperspectral imaging |
US11903563B2 (en) | 2019-06-20 | 2024-02-20 | Cilag Gmbh International | Offset illumination of a scene using multiple emitters in a fluorescence imaging system |
US11796466B2 (en) * | 2020-07-17 | 2023-10-24 | The Board of Regents for the Oklahoma Agricultural and Mechanical Colleges | System and method of non-contact glucose sensing |
ES1255295Y (en) * | 2020-07-28 | 2021-01-19 | Mingo Francisco Javier Garcia | VENOUS TRANSILUMINATOR |
CN112603268A (en) * | 2020-12-24 | 2021-04-06 | 华中光电技术研究所(中国船舶重工集团公司第七一七研究所) | Multi-mode optical microscopic imaging device and microscopic imaging method |
US11138734B1 (en) | 2021-02-19 | 2021-10-05 | Vr Media Technology, Inc. | Hyperspectral facial analysis system and method for personalized health scoring |
CN116327111B (en) * | 2023-02-28 | 2024-01-16 | 中山大学中山眼科中心 | Fundus blood vessel blood oxygen function coefficient measurement system and method based on fundus photo |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4934372A (en) * | 1985-04-01 | 1990-06-19 | Nellcor Incorporated | Method and apparatus for detecting optical pulses |
US4907876A (en) * | 1987-05-08 | 1990-03-13 | Hamamatsu Photonics Kabushiki Kaisha | Examination apparatus for measuring oxygenation in body organs |
JP3035336B2 (en) * | 1990-11-27 | 2000-04-24 | 興和株式会社 | Blood flow measurement device |
US5615673A (en) * | 1995-03-27 | 1997-04-01 | Massachusetts Institute Of Technology | Apparatus and methods of raman spectroscopy for analysis of blood gases and analytes |
US5606969A (en) * | 1995-03-31 | 1997-03-04 | Brigham & Women'hospital | Methods for measuring lung function using diffused light |
WO1996036273A2 (en) * | 1995-05-16 | 1996-11-21 | The United States Of America, Represented By The Secretary Of The Air Force | System and method for enhanced visualization of subcutaneous structures |
US6032070A (en) * | 1995-06-07 | 2000-02-29 | University Of Arkansas | Method and apparatus for detecting electro-magnetic reflection from biological tissue |
US5788639A (en) * | 1995-07-13 | 1998-08-04 | Lucid Technologies, Inc. | Confocal imaging through thick dermal tissue |
US5976502A (en) * | 1997-10-21 | 1999-11-02 | Gholam A. Peyman | Method of visualizing particles and blood cells containing a fluorescent lipophilic dye in the retina and choroid of the eye |
US6353753B1 (en) * | 1998-05-05 | 2002-03-05 | Stephen Thomas Flock | Optical imaging of deep anatomic structures |
US6178340B1 (en) * | 1998-08-24 | 2001-01-23 | Eduardo Svetliza | Three-dimensional infrared imager for subcutaneous puncture and study of vascular network |
-
2001
- 2001-05-03 WO PCT/US2001/014322 patent/WO2001082786A2/en active Application Filing
- 2001-05-03 AU AU2001259435A patent/AU2001259435A1/en not_active Abandoned
- 2001-05-03 US US09/848,596 patent/US6889075B2/en not_active Expired - Fee Related
-
2005
- 2005-01-14 US US11/036,548 patent/US20050143662A1/en not_active Abandoned
Cited By (192)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040082863A1 (en) * | 2002-03-15 | 2004-04-29 | Mcgreevy James | Device and method for the photodynamic diagnosis of tumor tissue |
US20050131284A1 (en) * | 2002-04-02 | 2005-06-16 | Yeda Research And Development Co. Ltd. | Characterization of moving objects in a stationary background |
US7912534B2 (en) * | 2002-04-02 | 2011-03-22 | Yeda Research And Development Co. Ltd. | Characterization of moving objects in a stationary background |
US8144942B2 (en) | 2002-05-09 | 2012-03-27 | Sony Corporation | Compact biometric authentication device and associated methodology of imaging and detecting living-tissue patterns |
US20110038511A1 (en) * | 2002-05-09 | 2011-02-17 | Sony Corporation | Compact biometric authentication device and associated methodology of imaging and detecting living-tissue patterns |
US10371629B2 (en) | 2002-05-09 | 2019-08-06 | Sony Corporation | Compact biometric authentication device and associated methodology of imaging and detecting living-tissue patterns |
US9234842B2 (en) | 2002-05-09 | 2016-01-12 | Sony Corporation | Compact biometric authentication device and associated methodology of imaging and detecting living-tissue patterns |
US8811680B2 (en) | 2002-05-09 | 2014-08-19 | Sony Corporation | Compact biometric authentication device and associated methodology of imaging and detecting living-tissue patterns |
US20060004292A1 (en) * | 2002-12-13 | 2006-01-05 | Alexander Beylin | Optical examination method and apparatus particularly useful for real-time discrimination of tumors from normal tissues during surgery |
US20070293766A1 (en) * | 2004-08-27 | 2007-12-20 | Koninklijke Philips Electronics N.V. | Transmission Based Imaging for Spectroscopic Analysis |
US20060250613A1 (en) * | 2005-04-14 | 2006-11-09 | Chem Image Corporation | Method and applications to enhance and image optical signals from biological objects |
US8172763B2 (en) | 2005-05-06 | 2012-05-08 | Yeda Research And Development Co., Ltd. | Imaging and analysis of movement of erythrocytes in blood vessels in relation to the cardiac cycle |
US20090221912A1 (en) * | 2005-05-06 | 2009-09-03 | Darin Nelson | Imaging and analysis of movement of erythrocytes in blood vessels in relation to the cardiac cycle |
US20070027362A1 (en) * | 2005-07-27 | 2007-02-01 | Olympus Medical Systems Corp. | Infrared observation system |
US9788787B2 (en) | 2006-01-10 | 2017-10-17 | Accuvein, Inc. | Patient-mounted micro vein enhancer |
US9125629B2 (en) | 2006-01-10 | 2015-09-08 | Accuvein, Inc. | Vial-mounted micro vein enhancer |
US11484260B2 (en) | 2006-01-10 | 2022-11-01 | Accuvein, Inc. | Patient-mounted micro vein enhancer |
US11638558B2 (en) | 2006-01-10 | 2023-05-02 | Accuvein, Inc. | Micro vein enhancer |
US11399768B2 (en) | 2006-01-10 | 2022-08-02 | Accuvein, Inc. | Scanned laser vein contrast enhancer utilizing surface topology |
US11642080B2 (en) | 2006-01-10 | 2023-05-09 | Accuvein, Inc. | Portable hand-held vein-image-enhancing device |
US9492117B2 (en) | 2006-01-10 | 2016-11-15 | Accuvein, Inc. | Practitioner-mounted micro vein enhancer |
US9854977B2 (en) | 2006-01-10 | 2018-01-02 | Accuvein, Inc. | Scanned laser vein contrast enhancer using a single laser, and modulation circuitry |
US9949688B2 (en) | 2006-01-10 | 2018-04-24 | Accuvein, Inc. | Micro vein enhancer with a dual buffer mode of operation |
US20070161909A1 (en) * | 2006-01-10 | 2007-07-12 | Ron Goldman | Micro Vein Enhancer |
US20070162094A1 (en) * | 2006-01-10 | 2007-07-12 | Ron Goldman | Micro vein enhancer |
US11357449B2 (en) | 2006-01-10 | 2022-06-14 | Accuvein, Inc. | Micro vein enhancer for hands-free imaging for a venipuncture procedure |
US10258748B2 (en) | 2006-01-10 | 2019-04-16 | Accuvein, Inc. | Vein scanner with user interface for controlling imaging parameters |
US9788788B2 (en) | 2006-01-10 | 2017-10-17 | AccuVein, Inc | Three dimensional imaging of veins |
US20070161907A1 (en) * | 2006-01-10 | 2007-07-12 | Ron Goldman | Micro vein enhancer |
US11278240B2 (en) | 2006-01-10 | 2022-03-22 | Accuvein, Inc. | Trigger-actuated laser vein contrast enhancer |
US7904138B2 (en) | 2006-01-10 | 2011-03-08 | Accuvein Llc | Micro vein enhancer |
US9044207B2 (en) | 2006-01-10 | 2015-06-02 | Accuvein, Inc. | Micro vein enhancer for use with a vial holder |
US11172880B2 (en) | 2006-01-10 | 2021-11-16 | Accuvein, Inc. | Vein imager with a dual buffer mode of operation |
US8073531B2 (en) | 2006-01-10 | 2011-12-06 | Accuvein, Llc | Micro vein enhancer |
US8818493B2 (en) | 2006-01-10 | 2014-08-26 | Accuvein, Inc. | Three-dimensional imaging of veins |
US10813588B2 (en) | 2006-01-10 | 2020-10-27 | Accuvein, Inc. | Micro vein enhancer |
US7983738B2 (en) | 2006-01-10 | 2011-07-19 | Accuvein, Llc | Three dimensional imaging of veins |
US20070161908A1 (en) * | 2006-01-10 | 2007-07-12 | Ron Goldman | Micro vein enhancer |
US20110208121A1 (en) * | 2006-01-10 | 2011-08-25 | Ron Goldman | Micro vein enhancer |
US9042966B2 (en) | 2006-01-10 | 2015-05-26 | Accuvein, Inc. | Three dimensional imaging of veins |
US11253198B2 (en) | 2006-01-10 | 2022-02-22 | Accuvein, Inc. | Stand-mounted scanned laser vein contrast enhancer |
US10617352B2 (en) | 2006-01-10 | 2020-04-14 | Accuvein, Inc. | Patient-mounted micro vein enhancer |
US8750970B2 (en) | 2006-01-10 | 2014-06-10 | Accu Vein, Inc. | Micro vein enhancer |
US8712498B2 (en) | 2006-01-10 | 2014-04-29 | Accuvein Inc. | Micro vein enhancer |
US8150500B2 (en) | 2006-01-10 | 2012-04-03 | Accuvein Inc. | Micro vein enhancer |
US20080004525A1 (en) * | 2006-01-10 | 2008-01-03 | Ron Goldman | Three dimensional imaging of veins |
US11191482B2 (en) | 2006-01-10 | 2021-12-07 | Accuvein, Inc. | Scanned laser vein contrast enhancer imaging in an alternating frame mode |
US8478386B2 (en) | 2006-01-10 | 2013-07-02 | Accuvein Inc. | Practitioner-mounted micro vein enhancer |
US10470706B2 (en) | 2006-01-10 | 2019-11-12 | Accuvein, Inc. | Micro vein enhancer for hands-free imaging for a venipuncture procedure |
US11109806B2 (en) | 2006-01-10 | 2021-09-07 | Accuvein, Inc. | Three dimensional imaging of veins |
US10500350B2 (en) | 2006-01-10 | 2019-12-10 | Accuvein, Inc. | Combination vein contrast enhancer and bar code scanning device |
US8295904B2 (en) | 2006-01-10 | 2012-10-23 | Accuvein, Llc | Micro vein enhancer |
US8665507B2 (en) | 2006-06-29 | 2014-03-04 | Accuvein, Inc. | Module mounting mirror endoscopy |
US8838210B2 (en) | 2006-06-29 | 2014-09-16 | AccuView, Inc. | Scanned laser vein contrast enhancer using a single laser |
US8255040B2 (en) | 2006-06-29 | 2012-08-28 | Accuvein, Llc | Micro vein enhancer |
US20080045841A1 (en) * | 2006-06-29 | 2008-02-21 | Fred Wood | Scanned laser vein contrast enhancer |
US8391960B2 (en) | 2006-06-29 | 2013-03-05 | Accuvein Inc. | Scanned laser vein contrast enhancer |
US8706200B2 (en) * | 2006-06-29 | 2014-04-22 | Accuvein, Inc. | Scanned laser vein contrast enhancer |
US8244333B2 (en) | 2006-06-29 | 2012-08-14 | Accuvein, Llc | Scanned laser vein contrast enhancer |
US20130123640A1 (en) * | 2006-06-29 | 2013-05-16 | Ron Goldman | Scanned Laser Vein Contrast Enhancer |
US20080287806A1 (en) * | 2006-06-29 | 2008-11-20 | Fred Wood | Scanned laser vein contrast enhancer |
US11051697B2 (en) | 2006-06-29 | 2021-07-06 | Accuvein, Inc. | Multispectral detection and presentation of an object's characteristics |
US8489178B2 (en) | 2006-06-29 | 2013-07-16 | Accuvein Inc. | Enhanced laser vein contrast enhancer with projection of analyzed vein data |
US20080177184A1 (en) * | 2006-06-29 | 2008-07-24 | Ron Goldman | Micro vein enhancer |
US20080045818A1 (en) * | 2006-06-29 | 2008-02-21 | Fred Wood | Laser vein contrast enhancer |
US9186063B2 (en) | 2006-06-29 | 2015-11-17 | Accu Vein, Inc. | Scanned laser vein contrast enhancer using one laser for a detection mode and a display mode |
US8594770B2 (en) * | 2006-06-29 | 2013-11-26 | Accuvein, Inc. | Multispectral detection and presentation of an object's characteristics |
US9345427B2 (en) | 2006-06-29 | 2016-05-24 | Accuvein, Inc. | Method of using a combination vein contrast enhancer and bar code scanning device |
US10357200B2 (en) * | 2006-06-29 | 2019-07-23 | Accuvein, Inc. | Scanning laser vein contrast enhancer having releasable handle and scan head |
US20080027317A1 (en) * | 2006-06-29 | 2008-01-31 | Fred Wood | Scanned laser vein contrast enhancer |
US11523739B2 (en) | 2006-06-29 | 2022-12-13 | Accuvein, Inc. | Multispectral detection and presentation of an object's characteristics |
US20080021329A1 (en) * | 2006-06-29 | 2008-01-24 | Fred Wood | Scanned laser vein contrast enhancer |
US10238294B2 (en) | 2006-06-29 | 2019-03-26 | Accuvein, Inc. | Scanned laser vein contrast enhancer using one laser |
US9226664B2 (en) | 2006-06-29 | 2016-01-05 | Accuvein, Inc. | Scanned laser vein contrast enhancer using a single laser |
US11051755B2 (en) | 2006-06-29 | 2021-07-06 | Accuvein, Inc. | Scanned laser vein contrast enhancer using a retro collective mirror |
US20110112407A1 (en) * | 2006-06-29 | 2011-05-12 | Fred Wood | Multispectral detection and presentation of an object's characteristics |
US8380291B2 (en) | 2006-06-29 | 2013-02-19 | Accuvein Inc. | Scanned laser vein contrast enhancer |
US20110118611A1 (en) * | 2006-06-29 | 2011-05-19 | Vincent Luciano | Module mounting mirror endoscopy |
US20100056936A1 (en) * | 2006-12-01 | 2010-03-04 | Hitoshi Fujii | Blood flow rate imaging device |
WO2008094252A3 (en) * | 2007-01-31 | 2009-03-26 | Venouslight Llc | Scanned laser vein contrast enhancer |
US7996068B2 (en) * | 2007-03-14 | 2011-08-09 | The Board Of Trustees Of The Leland Stanford Junior University | Surgical method and apparatus for identification of fluorescence |
WO2008112312A1 (en) * | 2007-03-14 | 2008-09-18 | Geneva Medical Imaging, Llc | Apparatus and method for phase-space reduction for imaging of fluorescing, scattering and/or absorbing structures |
US20090054767A1 (en) * | 2007-03-14 | 2009-02-26 | Nicholas Alexander Telischak | Surgical method and apparatus for identification of fluorescence |
JP2010524533A (en) * | 2007-04-19 | 2010-07-22 | アンスティテュ ド ラディオプロテクシオン エ ド スルテ ニュクレエール | Device that assists in diagnosis and progress prediction of pathophysiological tissue changes |
US20100121200A1 (en) * | 2007-04-19 | 2010-05-13 | Institut De Radioprotection Et De Surete Nucleaire | Diagnostic and prognostic assistance device for physiopathological tissue changes |
US8795628B2 (en) * | 2007-05-04 | 2014-08-05 | The Board Of Trustees Of The Leland Stanford Junior University | Molecular imaging of living subjects using Raman spectroscopy and labeled Raman nanoparticles |
US20100166650A1 (en) * | 2007-05-04 | 2010-07-01 | Gambhir Sanjiv S | Molecular imaging of living subjects using raman spectroscopy and labeled raman nanoparticles |
US10580119B2 (en) | 2007-06-28 | 2020-03-03 | Accuvein, Inc. | Automatic alignment of a contrast enhancement system |
US9430819B2 (en) | 2007-06-28 | 2016-08-30 | Accuvein, Inc. | Automatic alignment of a contrast enhancement system |
US10713766B2 (en) | 2007-06-28 | 2020-07-14 | Accuvein, Inc. | Automatic alignment of a contrast enhancement system |
US11132774B2 (en) | 2007-06-28 | 2021-09-28 | Accuvein, Inc. | Automatic alignment of a contrast enhancement system |
US8730321B2 (en) | 2007-06-28 | 2014-05-20 | Accuvein, Inc. | Automatic alignment of a contrast enhancement system |
US11847768B2 (en) | 2007-06-28 | 2023-12-19 | Accuvein Inc. | Automatic alignment of a contrast enhancement system |
US9760982B2 (en) | 2007-06-28 | 2017-09-12 | Accuvein, Inc. | Automatic alignment of a contrast enhancement system |
US10096096B2 (en) | 2007-06-28 | 2018-10-09 | Accuvein, Inc. | Automatic alignment of a contrast enhancement system |
US20090002488A1 (en) * | 2007-06-28 | 2009-01-01 | Vincent Luciano | Automatic alignment of a contrast enhancement system |
US8532355B2 (en) * | 2007-11-08 | 2013-09-10 | D4D Technologies, Llc | Lighting compensated dynamic texture mapping of 3-D models |
US20090123045A1 (en) * | 2007-11-08 | 2009-05-14 | D4D Technologies, Llc | Lighting Compensated Dynamic Texture Mapping of 3-D Models |
US20120236117A1 (en) * | 2007-11-08 | 2012-09-20 | D4D Technologies, Llc | Lighting Compensated Dynamic Texture Mapping of 3-D Models |
US8144954B2 (en) * | 2007-11-08 | 2012-03-27 | D4D Technologies, Llc | Lighting compensated dynamic texture mapping of 3-D models |
US20090141853A1 (en) * | 2007-11-30 | 2009-06-04 | Veronica Crews | Protective shield for ct scanning machine |
US20090143671A1 (en) * | 2007-12-03 | 2009-06-04 | Fujifilm Corporation | Position identifying system, position identifying method, and computer readable medium |
US8403862B2 (en) | 2007-12-20 | 2013-03-26 | Yeda Research And Development Co. Ltd. | Time-based imaging |
US8542357B2 (en) * | 2008-04-04 | 2013-09-24 | The University Of Tokyo | Method and device for measuring circular dichroism spectra |
US20110063617A1 (en) * | 2008-04-04 | 2011-03-17 | Hiromi Takahashi | Method and Device for Measuring Circular Dichroism Spectra |
US9042967B2 (en) | 2008-05-20 | 2015-05-26 | University Health Network | Device and method for wound imaging and monitoring |
US11284800B2 (en) | 2008-05-20 | 2022-03-29 | University Health Network | Devices, methods, and systems for fluorescence-based endoscopic imaging and collection of data with optical filters with corresponding discrete spectral bandwidth |
US11154198B2 (en) | 2008-05-20 | 2021-10-26 | University Health Network | Method and system for imaging and collection of data for diagnostic purposes |
US11375898B2 (en) | 2008-05-20 | 2022-07-05 | University Health Network | Method and system with spectral filtering and thermal mapping for imaging and collection of data for diagnostic purposes from bacteria |
US9789267B2 (en) | 2009-07-22 | 2017-10-17 | Accuvein, Inc. | Vein scanner with user interface |
US20110125028A1 (en) * | 2009-07-22 | 2011-05-26 | Fred Wood | Vein scanner |
US10518046B2 (en) | 2009-07-22 | 2019-12-31 | Accuvein, Inc. | Vein scanner with user interface |
US8463364B2 (en) | 2009-07-22 | 2013-06-11 | Accuvein Inc. | Vein scanner |
US11826166B2 (en) | 2009-07-22 | 2023-11-28 | Accuvein, Inc. | Vein scanner with housing configured for single-handed lifting and use |
USD999380S1 (en) | 2009-07-22 | 2023-09-19 | Accuvein, Inc. | Vein imager and cradle in combination |
US9061109B2 (en) | 2009-07-22 | 2015-06-23 | Accuvein, Inc. | Vein scanner with user interface |
US9155480B2 (en) * | 2009-09-04 | 2015-10-13 | The Johns Hopkins University | Multimodal laser speckle imaging |
US20120162438A1 (en) * | 2009-09-04 | 2012-06-28 | The John Hopkins University | Multimodal laser speckle imaging |
US10092190B2 (en) | 2009-09-04 | 2018-10-09 | The Johns Hopkins University | Multimodal laser speckle imaging |
EP2473102A4 (en) * | 2009-09-04 | 2015-09-16 | Univ Johns Hopkins | Multimodal laser speckle imaging |
US9451882B2 (en) | 2009-12-15 | 2016-09-27 | Emory University | Integrated system and methods for real-time anatomical guidance in a diagnostic or therapeutic procedure |
US9134243B2 (en) * | 2009-12-18 | 2015-09-15 | University Health Network | System and method for sub-surface fluorescence imaging |
US20120326055A1 (en) * | 2009-12-18 | 2012-12-27 | University Health Network | System and method for sub-surface fluorescence imaging |
USD999379S1 (en) | 2010-07-22 | 2023-09-19 | Accuvein, Inc. | Vein imager and cradle in combination |
WO2012011951A1 (en) * | 2010-07-22 | 2012-01-26 | Accuvein, L.L.C. | Vein scanner |
USD998152S1 (en) | 2010-07-22 | 2023-09-05 | Accuvein, Inc. | Vein imager cradle |
US8586924B2 (en) * | 2010-09-13 | 2013-11-19 | Lawrence Livermore National Security, Llc | Enhancement of the visibility of objects located below the surface of a scattering medium |
US20120062897A1 (en) * | 2010-09-13 | 2012-03-15 | Stavros Demos | Enhancement of the visibility of objects located below the surface of a scattering medium |
US20120120245A1 (en) * | 2010-11-15 | 2012-05-17 | Intuitive Surgical Operations, Inc. | System and method for multi-resolution sharpness transport across color channels |
US9697588B2 (en) * | 2010-11-15 | 2017-07-04 | Intuitive Surgical Operations, Inc. | System and method for multi-resolution sharpness transport across color channels |
US10089724B2 (en) | 2010-11-15 | 2018-10-02 | Intuitive Surgical Operations, Inc. | System and method for multi-resolution sharpness transport across color channels |
US8639306B2 (en) | 2011-02-07 | 2014-01-28 | Brien Holden Vision Diagnostics, Inc. | Noninvasive eye-property monitoring, including aqueous-humor glucose monitoring as an indication of blood glucose level |
WO2012109116A2 (en) * | 2011-02-07 | 2012-08-16 | Quantum Catch, Llc | Noninvasive eye-property monitoring, including aqueous-humor glucose monitoring as an indication of blood glucose level |
WO2012109116A3 (en) * | 2011-02-07 | 2013-04-25 | Quantum Catch Corporation | Noninvasive eye-property monitoring, including aqueous-humor glucose monitoring as an indication of blood glucose level |
US10420466B2 (en) | 2011-03-02 | 2019-09-24 | Brien Holden Vision Insititute Limited | Ocular fundus camera system and methodology |
US9247876B2 (en) | 2011-03-02 | 2016-02-02 | Brien Holden Vision Diagnostics, Inc. | Ocular fundus camera system and methodology |
US9936869B2 (en) | 2011-03-02 | 2018-04-10 | Brien Holden Vision Institute | Ocular fundus camera system and methodology |
US9579018B2 (en) | 2011-03-02 | 2017-02-28 | Brien Holden Vision Diagnostics, Inc. | Ocular fundus camera system and methodology |
US20120271176A1 (en) * | 2011-04-21 | 2012-10-25 | Moghaddam Hassan Ghaderi | Method and system for optically evaluating proximity to the inferior alveolar nerve in situ |
US9179843B2 (en) * | 2011-04-21 | 2015-11-10 | Hassan Ghaderi MOGHADDAM | Method and system for optically evaluating proximity to the inferior alveolar nerve in situ |
US10258350B2 (en) | 2011-04-21 | 2019-04-16 | Live Vue Technologies Inc. | Method and system for optically evaluating drilling proximity to the inferior alveolar nerve in situ |
US9848787B2 (en) | 2012-02-07 | 2017-12-26 | Laser Associated Sciences, Inc. | Perfusion assessment using transmission laser speckle imaging |
US11800990B2 (en) | 2012-02-07 | 2023-10-31 | Covidien Ag | Perfusion assessment using transmission laser speckle imaging |
US11399898B2 (en) | 2012-03-06 | 2022-08-02 | Briteseed, Llc | User interface for a system used to determine tissue or artifact characteristics |
US9375196B2 (en) | 2012-07-12 | 2016-06-28 | Covidien Lp | System and method for detecting critical structures using ultrasound |
US9730672B2 (en) | 2012-07-12 | 2017-08-15 | Covidien Lp | System and method for detecting critical structures using ultrasound |
US10568518B2 (en) | 2012-08-02 | 2020-02-25 | Accuvein, Inc. | Device for detecting and illuminating the vasculature using an FPGA |
US9782079B2 (en) | 2012-08-02 | 2017-10-10 | Accuvein, Inc. | Device for detecting and illuminating the vasculature using an FPGA |
US11510617B2 (en) | 2012-08-02 | 2022-11-29 | Accuvein, Inc. | Device for detecting and illuminating the vasculature using an FPGA |
US10322194B2 (en) | 2012-08-31 | 2019-06-18 | Sloan-Kettering Institute For Cancer Research | Particles, methods and uses thereof |
WO2014043378A1 (en) * | 2012-09-12 | 2014-03-20 | The General Hospital Corporation | Apparatus and method for volumetric imaging of blood flow properties |
US11439307B2 (en) | 2012-12-05 | 2022-09-13 | Accuvein, Inc. | Method for detecting fluorescence and ablating cancer cells of a target surgical area |
US20140187967A1 (en) * | 2012-12-05 | 2014-07-03 | Fred Wood | System and Method for Multi-Color Laser Imaging and Ablation of Cancer Cells Using Fluorescence |
US10376147B2 (en) * | 2012-12-05 | 2019-08-13 | AccuVeiw, Inc. | System and method for multi-color laser imaging and ablation of cancer cells using fluorescence |
US10376148B2 (en) | 2012-12-05 | 2019-08-13 | Accuvein, Inc. | System and method for laser imaging and ablation of cancer cells using fluorescence |
US10517483B2 (en) | 2012-12-05 | 2019-12-31 | Accuvein, Inc. | System for detecting fluorescence and projecting a representative image |
US10105456B2 (en) | 2012-12-19 | 2018-10-23 | Sloan-Kettering Institute For Cancer Research | Multimodal particles, methods and uses thereof |
US10888227B2 (en) | 2013-02-20 | 2021-01-12 | Memorial Sloan Kettering Cancer Center | Raman-triggered ablation/resection systems and methods |
US20160000329A1 (en) * | 2013-02-20 | 2016-01-07 | Sloan-Kettering Institute For Cancer Research | Wide field raman imaging apparatus and associated methods |
US10441177B2 (en) | 2013-07-23 | 2019-10-15 | Bae Systems Information And Electronic Systems Integration Inc. | High definition thermal imaging for medical applications |
WO2015117084A1 (en) * | 2014-02-03 | 2015-08-06 | The Board Of Trustees Of The Leland Stanford Junior University | Contact-free physiological monitoring during simultaneous magnetic resonance imaging |
US10912947B2 (en) | 2014-03-04 | 2021-02-09 | Memorial Sloan Kettering Cancer Center | Systems and methods for treatment of disease via application of mechanical force by controlled rotation of nanoparticles inside cells |
US10251600B2 (en) | 2014-03-25 | 2019-04-09 | Briteseed, Llc | Vessel detector and method of detection |
US11676276B2 (en) | 2014-07-24 | 2023-06-13 | University Health Network | Collection and analysis of data for diagnostic purposes |
US11954861B2 (en) | 2014-07-24 | 2024-04-09 | University Health Network | Systems, devices, and methods for visualization of tissue and collection and analysis of data regarding same |
US10438356B2 (en) | 2014-07-24 | 2019-10-08 | University Health Network | Collection and analysis of data for diagnostic purposes |
US10688202B2 (en) | 2014-07-28 | 2020-06-23 | Memorial Sloan-Kettering Cancer Center | Metal(loid) chalcogen nanoparticles as universal binders for medical isotopes |
WO2016069086A1 (en) * | 2014-10-30 | 2016-05-06 | Bae Systems Information & Electronic Systems Integration Inc. | High definition thermal imaging for medical applications |
US10524677B2 (en) | 2014-11-24 | 2020-01-07 | Verily Life Sciences Llc | Applications of vasculature mapping using laser speckle imaging |
US9839365B1 (en) * | 2014-11-24 | 2017-12-12 | Verily Life Sciences Llc | Applications of vasculature mapping using laser speckle imaging |
US11490820B2 (en) | 2015-02-19 | 2022-11-08 | Briteseed, Llc | System and method for determining vessel size and/or edge |
US10820838B2 (en) | 2015-02-19 | 2020-11-03 | Briteseed, Llc | System for determining vessel size using light absorption |
KR101647022B1 (en) * | 2015-02-23 | 2016-08-10 | 연세대학교 원주산학협력단 | Apparatus and method for capturing medical image |
US10919089B2 (en) | 2015-07-01 | 2021-02-16 | Memorial Sloan Kettering Cancer Center | Anisotropic particles, methods and uses thereof |
KR102491850B1 (en) | 2015-07-15 | 2023-01-26 | 삼성전자주식회사 | Imaging system and mentod of laser speckle contrast and apparatus employing the same |
KR20170009085A (en) * | 2015-07-15 | 2017-01-25 | 삼성전자주식회사 | Imaging system and mentod of laser speckle contrast and apparatus employing the same |
US10716508B2 (en) | 2015-10-08 | 2020-07-21 | Briteseed, Llc | System and method for determining vessel size |
US10413272B2 (en) | 2016-03-08 | 2019-09-17 | Covidien Lp | Surgical tool with flex circuit ultrasound sensor |
US11484285B2 (en) | 2016-03-08 | 2022-11-01 | Covidien Lp | Surgical tool with flex circuit ultrasound sensor |
US11709120B2 (en) | 2016-04-06 | 2023-07-25 | Covidien Ag | System for blood flow measurement with affixed laser speckle contrast analysis |
WO2017176781A1 (en) * | 2016-04-06 | 2017-10-12 | Laser Associated Sciences, LLC | System for blood flow measurement with affixed laser speckle contrast analysis |
CN109152544B (en) * | 2016-04-06 | 2021-09-10 | 雷瑟联合科技有限公司 | Blood flow measurement system using adherent laser speckle contrast analysis |
CN109152544A (en) * | 2016-04-06 | 2019-01-04 | 雷瑟联合科技有限公司 | Use the blood flow system for measuring quantity of adherency laser speckle comparative analysis |
US10631838B2 (en) | 2016-05-03 | 2020-04-28 | Covidien Lp | Devices, systems, and methods for locating pressure sensitive critical structures |
US11589852B2 (en) | 2016-08-30 | 2023-02-28 | Briteseed, Llc | Optical surgical system having light sensor on its jaw and method for determining vessel size with angular distortion compensation |
US10813597B2 (en) | 2017-04-14 | 2020-10-27 | The Regents Of The University Of California | Non-invasive hemodynamic assessment via interrogation of biological tissue using a coherent light source |
US11207024B2 (en) * | 2017-07-12 | 2021-12-28 | Boe Technology Group Co., Ltd. | Vascular imaging apparatus and vascular imaging method |
US11723600B2 (en) | 2017-09-05 | 2023-08-15 | Briteseed, Llc | System and method used to determine tissue and/or artifact characteristics |
US11696777B2 (en) | 2017-12-22 | 2023-07-11 | Briteseed, Llc | Compact system used to determine tissue or artifact characteristics |
US11711596B2 (en) | 2020-01-23 | 2023-07-25 | Covidien Lp | System and methods for determining proximity relative to an anatomical structure |
EP4205692A1 (en) * | 2021-12-30 | 2023-07-05 | Karl Storz Imaging, Inc. | Systems and methods for generating metamerically matched illumination |
US11961236B2 (en) | 2023-06-13 | 2024-04-16 | University Health Network | Collection and analysis of data for diagnostic purposes |
Also Published As
Publication number | Publication date |
---|---|
WO2001082786A2 (en) | 2001-11-08 |
WO2001082786A3 (en) | 2002-05-23 |
US6889075B2 (en) | 2005-05-03 |
US20020016533A1 (en) | 2002-02-07 |
AU2001259435A1 (en) | 2001-11-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6889075B2 (en) | Optical imaging of subsurface anatomical structures and biomolecules | |
WO2001050955A1 (en) | Improved endoscopic imaging and treatment of anatomic structures | |
US6353753B1 (en) | Optical imaging of deep anatomic structures | |
US8948851B2 (en) | Method and apparatus for depth-resolved fluorescence, chromophore, and oximetry imaging for lesion identification during surgery | |
Kim et al. | Functional optical coherence tomography: principles and progress | |
Jayachandran et al. | Critical review of noninvasive optical technologies for wound imaging | |
Balas | Review of biomedical optical imaging—a powerful, non-invasive, non-ionizing technology for improving in vivo diagnosis | |
US8868161B2 (en) | Detection and display of measured subsurface data onto a surface | |
US20080306337A1 (en) | Characterization of a Near-Infrared Laparoscopic Hyperspectral Imaging System for Minimally Invasive Surgery | |
US20030139667A1 (en) | Tissue viability/health monitor utilizing near infrared spectroscopy | |
Borisova et al. | Optical biopsy of human skin-A tool for cutaneous tumours' diagnosis | |
US11779246B2 (en) | Hemoglobin measurement from a single vessel | |
JP4721144B2 (en) | Measuring method and measuring device | |
KR20160089355A (en) | Device for non-invasive detection of predetermined biological structures | |
WO2006116672A2 (en) | Systems and methods for tomographic image reconstruction | |
US20160066833A1 (en) | Device and method for imaging collagen structure in vivo | |
Kyriacou et al. | The origin of photoplethysmography | |
Zuzak et al. | The robustness of DLP hyperspectral imaging for clinical and surgical utility | |
Välisuo | Optical methods for assessing skin flap survival | |
Nioka et al. | Optical tecnology developments in biomedicine: history, current and future | |
Zhao et al. | A new approach for noninvasive skin blood imaging in microcirculation | |
Berezhnoi | Development of multi-wavelength optoacoustic mesoscopy for high resolution morphological and functional imaging of skin | |
손태윤 | Preclinicalapplication of laser speckle imaging and development of multimodal optical imaging system | |
Vilaseca et al. | Asian Journal of Physics | |
Gray et al. | Conference 8214: Advanced Biomedical and Clinical Diagnostic Systems X |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |